1
|
Dalle Carbonare L, Basile A, Rindi L, Bulleri F, Hamedeh H, Iacopino S, Shukla V, Weits DA, Lombardi L, Sbrana A, Benedetti-Cecchi L, Giuntoli B, Licausi F, Maggi E. Dim artificial light at night alters gene expression rhythms and growth in a key seagrass species (Posidonia oceanica). Sci Rep 2023; 13:10620. [PMID: 37391536 PMCID: PMC10313690 DOI: 10.1038/s41598-023-37261-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/08/2022] [Accepted: 06/19/2023] [Indexed: 07/02/2023] Open
Abstract
Artificial light at night (ALAN) is a globally spreading anthropogenic stressor, affecting more than 20% of coastal habitats. The alteration of the natural light/darkness cycle is expected to impact the physiology of organisms by acting on the complex circuits termed as circadian rhythms. Our understanding of the impact of ALAN on marine organisms is lagging behind that of terrestrial ones, and effects on marine primary producers are almost unexplored. Here, we investigated the molecular and physiological response of the Mediterranean seagrass, Posidonia oceanica (L.) Delile, as model to evaluate the effect of ALAN on seagrass populations established in shallow waters, by taking advantage of a decreasing gradient of dim nocturnal light intensity (from < 0.01 to 4 lx) along the NW Mediterranean coastline. We first monitored the fluctuations of putative circadian-clock genes over a period of 24 h along the ALAN gradient. We then investigated whether key physiological processes, known to be synchronized with day length by the circadian rhythm, were also affected by ALAN. ALAN influenced the light signalling at dusk/night in P. oceanica, including that of shorter blue wavelengths, through the ELF3-LUX1-ZTL regulatory network, and suggested that the daily perturbation of internal clock orthologs in seagrass might have caused the recruitment of PoSEND33 and PoPSBS genes to mitigate the repercussions of a nocturnal stress on photosynthesis during the day. A long-lasting impairment of gene fluctuations in sites characterised by ALAN could explain the reduced growth of the seagrass leaves when these were transferred into controlled conditions and without lighting during the night. Our results highlight the potential contribution of ALAN to the global loss of seagrass meadows, posing questions about key interactions with a variety of other human-related stressors in urban areas, in order to develop more efficient strategies to globally preserve these coastal foundation species.
Collapse
Affiliation(s)
- L Dalle Carbonare
- Institute of Life Sciences, Scuola Superiore Sant'Anna, Piazza Martiri Della Libertà, 56127, Pisa, Italy.
- Department of Biology, University of Oxford, Oxford, OX1 3RB, UK.
| | - A Basile
- Institute of Life Sciences, Scuola Superiore Sant'Anna, Piazza Martiri Della Libertà, 56127, Pisa, Italy
| | - L Rindi
- Dipartimento di Biologia, Universita' di Pisa, CoNISMa, Via Luca Ghini 13, 56126, Pisa, Italy
| | - F Bulleri
- Dipartimento di Biologia, Universita' di Pisa, CoNISMa, Via Luca Ghini 13, 56126, Pisa, Italy
| | - H Hamedeh
- Institute of Life Sciences, Scuola Superiore Sant'Anna, Piazza Martiri Della Libertà, 56127, Pisa, Italy
| | - S Iacopino
- Institute of Life Sciences, Scuola Superiore Sant'Anna, Piazza Martiri Della Libertà, 56127, Pisa, Italy
| | - V Shukla
- Institute of Life Sciences, Scuola Superiore Sant'Anna, Piazza Martiri Della Libertà, 56127, Pisa, Italy
| | - D A Weits
- Institute of Life Sciences, Scuola Superiore Sant'Anna, Piazza Martiri Della Libertà, 56127, Pisa, Italy
| | - L Lombardi
- Dipartimento di Biologia, Universita' di Pisa, CoNISMa, Via Luca Ghini 13, 56126, Pisa, Italy
| | - A Sbrana
- Dipartimento di Biologia, Universita' di Pisa, CoNISMa, Via Luca Ghini 13, 56126, Pisa, Italy
| | - L Benedetti-Cecchi
- Dipartimento di Biologia, Universita' di Pisa, CoNISMa, Via Luca Ghini 13, 56126, Pisa, Italy
| | - B Giuntoli
- Institute of Life Sciences, Scuola Superiore Sant'Anna, Piazza Martiri Della Libertà, 56127, Pisa, Italy
- Dipartimento di Biologia, Universita' di Pisa, CoNISMa, Via Luca Ghini 13, 56126, Pisa, Italy
| | - F Licausi
- Department of Biology, University of Oxford, Oxford, OX1 3RB, UK
| | - E Maggi
- Dipartimento di Biologia, Universita' di Pisa, CoNISMa, Via Luca Ghini 13, 56126, Pisa, Italy.
| |
Collapse
|
2
|
Ros E, Tom T, Ortega P, Martin I, Maggi E, Asensi JM, López-Vidrier J, Saucedo E, Bertomeu J, Puigdollers J, Voz C. Elimination of Interface Energy Barriers Using Dendrimer Polyelectrolytes with Fractal Geometry. ACS Appl Mater Interfaces 2023; 15:28705-28715. [PMID: 37269290 PMCID: PMC10802975 DOI: 10.1021/acsami.3c01930] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 02/10/2023] [Accepted: 05/19/2023] [Indexed: 06/05/2023]
Abstract
In this work we study conjugated polyelectrolyte (CPE) films based on polyamidoamine (PAMAM) dendrimers of generations G1 and G3. These fractal macromolecules are compared to branched polyethylenimine (b-PEI) polymer using methanol as the solvent. All of these materials present a high density of amino groups, which protonated by methoxide counter-anions create strong dipolar interfaces. The vacuum level shift associated to these films on n-type silicon was 0.93 eV for b-PEI, 0.72 eV for PAMAM G1 and 1.07 eV for PAMAM G3. These surface potentials were enough to overcome Fermi level pinning, which is a typical limitation of aluminium contacts on n-type silicon. A specific contact resistance as low as 20 mΩ·cm2 was achieved with PAMAM G3, in agreement with the higher surface potential of this material. Good electron transport properties were also obtained for the other materials. Proof-of-concept silicon solar cells combining vanadium oxide as a hole-selective contact with these new electron transport layers have been fabricated and compared. The solar cell with PAMAM G3 surpassed 15% conversion efficiency with an overall increase of all the photovoltaic parameters. The performance of these devices correlates with compositional and nanostructural studies of the different CPE films. Particularly, a figure-of-merit (Vσ) for CPE films that considers the number of protonated amino groups per macromolecule has been introduced. The fractal geometry of dendrimers leads to a geometric increase in the number of amino groups per generation. Thus, investigation of dendrimer macromolecules seems a very good strategy to design CPE films with enhanced charge-carrier selectivity.
Collapse
Affiliation(s)
- E. Ros
- Departament
d’Enginyeria Electrònica, Universitat Politècnica de Catalunya (UPC), Barcelona 08034, Spain
| | - T. Tom
- Departament
de Física Aplicada, Universitat de
Barcelona, Martí i Franquès 1, 08028 Barcelona, Spain
- Institute
of Nanoscience and Nanotechnology (IN2UB), Universitat de Barcelona, Barcelona 08028, Spain
| | - P. Ortega
- Departament
d’Enginyeria Electrònica, Universitat Politècnica de Catalunya (UPC), Barcelona 08034, Spain
| | - I. Martin
- Departament
d’Enginyeria Electrònica, Universitat Politècnica de Catalunya (UPC), Barcelona 08034, Spain
| | - E. Maggi
- Departament
d’Enginyeria Electrònica, Universitat Politècnica de Catalunya (UPC), Barcelona 08034, Spain
| | - J. M. Asensi
- Departament
de Física Aplicada, Universitat de
Barcelona, Martí i Franquès 1, 08028 Barcelona, Spain
- Institute
of Nanoscience and Nanotechnology (IN2UB), Universitat de Barcelona, Barcelona 08028, Spain
| | - J. López-Vidrier
- Departament
de Física Aplicada, Universitat de
Barcelona, Martí i Franquès 1, 08028 Barcelona, Spain
- Institute
of Nanoscience and Nanotechnology (IN2UB), Universitat de Barcelona, Barcelona 08028, Spain
| | - E. Saucedo
- Departament
d’Enginyeria Electrònica, Universitat Politècnica de Catalunya (UPC), Barcelona 08034, Spain
| | - J. Bertomeu
- Departament
de Física Aplicada, Universitat de
Barcelona, Martí i Franquès 1, 08028 Barcelona, Spain
- Institute
of Nanoscience and Nanotechnology (IN2UB), Universitat de Barcelona, Barcelona 08028, Spain
| | - J. Puigdollers
- Departament
d’Enginyeria Electrònica, Universitat Politècnica de Catalunya (UPC), Barcelona 08034, Spain
| | - C. Voz
- Departament
d’Enginyeria Electrònica, Universitat Politècnica de Catalunya (UPC), Barcelona 08034, Spain
| |
Collapse
|
3
|
Scarabino D, Peconi M, Broggio E, Gambina G, Maggi E, Armeli F, Mantuano E, Morello M, Corbo RM, Businaro R. Relationship between proinflammatory cytokines (Il-1beta, Il-18) and leukocyte telomere length in mild cognitive impairment and Alzheimer's disease. Exp Gerontol 2020; 136:110945. [PMID: 32289486 DOI: 10.1016/j.exger.2020.110945] [Citation(s) in RCA: 24] [Impact Index Per Article: 6.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/29/2020] [Revised: 04/06/2020] [Accepted: 04/06/2020] [Indexed: 01/25/2023]
Abstract
Inflammation plays a crucial role in Alzheimer's disease (AD). AD neurodegeneration and concurrent involvement of the peripheral immune system may promote leukocyte division and telomere shortening. We examined genotypes and plasma levels of two proinflammatory cytokines, IL-1beta and IL-18, and leukocyte telomere length (LTL) in patients with mild cognitive impairment (MCI) and AD. We wanted to determine whether changes in plasma IL-1beta and IL-18 levels, together with LTL shortening, could be diagnostic for disease progression from MCI to AD. Median plasma IL-1beta levels were in the order MCI patients (2.2 pg/ml) < AD patients (4.0 pg/ml), both of which differed significantly from the controls (0.0 pg/ml). In the AD patients, the lowest IL-1beta levels were associated with the presence of the C allele of IL-1beta rs16944 SNP. Median plasma IL-18 levels were in the order MCI patients (116.3 pg/ml) > AD patients (85.8 pg/ml), both of which were significantly higher than in the controls (17.6 pg/ml). Analysis of LTL showed a progressive reduction in the order controls > MCI > AD patients (p < 0.0001). Overall LTL reduction was correlated with increased plasma IL-1beta levels, substantiating the hypothesis that inflammatory processes secondary to neuroinflammation may trigger telomere attrition. Changes in plasma IL-1beta and Il-18 levels, and LTL seem to reflect shifts in AD stage; they may have potential use as blood biomarkers to monitor disease onset and progression from MCI to AD.
Collapse
Affiliation(s)
- D Scarabino
- Institute of Molecular Biology and Pathology, National Research Council, Rome, Italy
| | - M Peconi
- Department of Human Neuroscience, Sapienza University of Rome, Rome, Italy
| | - E Broggio
- Alzheimer's Disease Center, Department of Neuroscience, University and Hospital of Verona, Verona, Italy
| | - G Gambina
- Alzheimer's Disease Center, Department of Neuroscience, University and Hospital of Verona, Verona, Italy
| | - E Maggi
- Department of Medico-Surgical Sciences and Biotechnologies, Sapienza University of Rome, Italy
| | - F Armeli
- Department of Medico-Surgical Sciences and Biotechnologies, Sapienza University of Rome, Italy
| | - E Mantuano
- Institute of Translational Pharmacology, National Research Council, Rome, Italy
| | - M Morello
- Department of Experimental Medicine and Surgery, Tor Vergata University, Rome, Italy
| | - R M Corbo
- Department of Biology and Biotechnology, La Sapienza University, Rome, Italy.
| | - R Businaro
- Department of Medico-Surgical Sciences and Biotechnologies, Sapienza University of Rome, Italy
| |
Collapse
|
4
|
Vultaggio A, Nencini F, Carraresi A, Pratesi S, Movérare R, Eriksson C, Venemalm L, Maggi E, Matucci A. IgG4 anti-infliximab in treated patients: Clinical impact and temporal evolution. Allergy 2018; 73:2172-2181. [PMID: 29719053 DOI: 10.1111/all.13471] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 04/23/2018] [Indexed: 01/04/2023]
Abstract
BACKGROUND Infliximab (IFX) carries potential risk of immunogenicity with the production of anti-drug antibodies (ADA). ADA may belong to different isotypes and are usually measured by ELISA bridging assay. This test is not designed to detect IgG4 antibodies. The aim was to measure IgG4 anti-IFX antibodies in a cohort of IFX-treated patients and to evaluate their relationship with ADA and their clinical impact. METHODS Anti-drug antibodies were detected using a bridging ELISA in the serum of 222 treated patients with different clinical outcomes to IFX. The same samples were analyzed for IgG4 anti-IFX antibodies using an experimental ImmunoCAP assay with reduced serum IgG4 background levels. A longitudinal evaluation was performed in a subgroup of 38 patients to define the temporal evolution of IgG4 anti-IFX. RESULTS IgG4 anti-IFX was found in 26.6% of patients. Eighty of 222 patients were ADA+ (36%) and the majority (57/80, 71.3%) had IgG4 anti-IFX. Two IgG4-positive but ADA-negative patients were identified. IgG4 anti-IFX levels correlated with the serum levels of ADA. IgG4 anti-IFX was more common in both reactive and nonresponder patients than in tolerant/responder patients. Patients who had experienced IgE-mediated reactions displayed significantly higher IgG4 anti-IFX than IgE-negative reactive patients. The majority of patients tested positive for IgG4 anti-IFX after the first seven infusions. CONCLUSIONS IgG4 anti-IFX is common in treated patients and a large part of ADA producing patients produce IgG4 antibodies. The IgG4 anti-IFX response does not prevent hypersensitivity reactions to IFX and correlates with the IgE anti-IFX response.
Collapse
Affiliation(s)
- A. Vultaggio
- Immunoallergology Unit Department of Biomedicine; Careggi University Hospital; Florence Italy
| | - F. Nencini
- Centre for Research Transfer and High Education DENOTHE and Department of Experimental and Clinical Medicine; University of Florence; Florence Italy
| | - A. Carraresi
- Immunoallergology Unit Department of Biomedicine; Careggi University Hospital; Florence Italy
| | - S. Pratesi
- Centre for Research Transfer and High Education DENOTHE and Department of Experimental and Clinical Medicine; University of Florence; Florence Italy
| | - R. Movérare
- Thermo Fisher Scientific ImmunoDiagnostics; Uppsala Sweden
- Department of Medical Sciences Respiratory, Allergy and Sleep Research; Uppsala University; Uppsala Sweden
| | - C. Eriksson
- Thermo Fisher Scientific ImmunoDiagnostics; Uppsala Sweden
| | - L. Venemalm
- Thermo Fisher Scientific ImmunoDiagnostics; Uppsala Sweden
| | - E. Maggi
- Centre for Research Transfer and High Education DENOTHE and Department of Experimental and Clinical Medicine; University of Florence; Florence Italy
| | - A. Matucci
- Immunoallergology Unit Department of Biomedicine; Careggi University Hospital; Florence Italy
| |
Collapse
|
5
|
Maggi E, Puccinelli E, Benedetti-Cecchi L. Ecological feedback mechanisms and variable disturbance regimes: the uncertain future of Mediterranean macroalgal forests. Mar Environ Res 2018; 140:342-357. [PMID: 30017202 DOI: 10.1016/j.marenvres.2018.07.002] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 04/03/2018] [Revised: 07/08/2018] [Accepted: 07/08/2018] [Indexed: 06/08/2023]
Abstract
Loss of algal canopies can result in a shift towards a turf-dominated state, where variability in species life-history traits can determine new mechanisms of feedback, and influence the degraded system under variable regimes of disturbance. By focusing on rockpools dominated by Cystoseira brachycarpa, we tested the hypothesis that the alga Dictyopteris polypodioides could take advantage of extreme regimes of disturbance related to storms, and outcompete other turfs through a distinctive combination of life traits. Replacement of the canopy was initially driven by a mix of taxon-specific life-traits and resulting assemblages were susceptible to intense events of disturbance. Subsequently, D. polypodioides dominated removal quadrats, favored by density-dependent abilities to intercept more light and reach larger size than the rest of turf. These new positive feedbacks may contribute to maintain the modified state of the system and influence its ability to withstand extreme abiotic conditions.
Collapse
Affiliation(s)
- E Maggi
- Dipartimento di Biologia, CoNISMa, Università di Pisa, Italy.
| | - E Puccinelli
- Oceanography Department, Marine Research Institute, University of Cape Town, South Africa
| | | |
Collapse
|
6
|
Tognetti L, Rubegni P, Vitiello G, Bormioli S, Carraro A, Cinotti E, Fimiani M, Maggi E. Persistent unilateral ulcer of the ear as the first manifestation of relapsing polychondritis. Clin Exp Dermatol 2018; 43:823-824. [PMID: 29770469 DOI: 10.1111/ced.13615] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 01/02/2018] [Indexed: 11/28/2022]
Affiliation(s)
- L Tognetti
- Division of Dermatology, Department of Medical, Surgical and Neuro-Sciences, University of Siena, Siena, Italy.,Department of Medical Biotechnologies, University of Siena, Siena, Italy
| | - P Rubegni
- Division of Dermatology, Department of Medical, Surgical and Neuro-Sciences, University of Siena, Siena, Italy
| | - G Vitiello
- Experimental and Clinical Medicine Department, University of Florence, Florence, Italy
| | - S Bormioli
- Experimental and Clinical Medicine Department, University of Florence, Florence, Italy
| | - A Carraro
- Division of Dermatology, Department of Medical, Surgical and Neuro-Sciences, University of Siena, Siena, Italy
| | - E Cinotti
- Division of Dermatology, Department of Medical, Surgical and Neuro-Sciences, University of Siena, Siena, Italy
| | - M Fimiani
- Division of Dermatology, Department of Medical, Surgical and Neuro-Sciences, University of Siena, Siena, Italy
| | - E Maggi
- Experimental and Clinical Medicine Department, University of Florence, Florence, Italy
| |
Collapse
|
7
|
Maggi E, Macchia D, Parronchi P, Milo D, Romagnani S. Diminished Production of Interleukin 2 and Gamma-Interferon by Cloned «T» Cells from Patients with the Acquired Immunodeficiency Syndrome (AIDS). Tumori 2018; 73:273-8. [PMID: 3111045 DOI: 10.1177/030089168707300311] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
Abstract
A total of 76 T-cell clones established from peripheral blood (PB) of 2 patients with the acquired immune deficiency syndrome (AIDS) and of 141 T-cell clones established from PB of 3 normal donors were compared for their ability to produce interleukin 2 (IL-2) and gamma-interferon (γ-IFN). Twenty-seven clones from AIDS patients and 85 clones from controls expressed the CD4 phenotype, whereas 49 clones from AIDS patients and 56 clones from controls expressed the CD8 phenotype. There were no significant differences in the proportions of IL-2-producing CD4 T-cell clones established from PB of patients with AIDS and controls, but the mean concentration of IL-2 produced by CD4 clones from AIDS patients was significantly lower than that produced by CD4 clones from controls. Both the proportion of γ-IFN-producing CD4 clones and the mean concentration of γ-IFN produced by CD4 clones were significantly lower in AIDS patients than in controls. In contrast, there were no differences between AIDS patients and normal individuals in the proportion of IL-2- or Y-IFN-producing CD8 clones, or in the mean concentration of IL-2 and v-IFN produced by CD8 clones. These data suggest that the reduced ability of PB T-cells from patients with AIDS to produce IL-2 and v-IFN is not simply due to altered proportions or numbers of T-cell sub-populations, but also reflects intrinsic abnormalities of individual CD4 T lymphocytes.
Collapse
|
8
|
Maggi E, Impagliazzo M, Minnella A, Zanardi N, Izzo M, Campone F, Blanchi I, Tacchino C, Shimatani K, Shima K, Tsuji T, Giannoni P, Fato M, Morasso P, Casadio M, Ramenghi L, Moretti P. A new method for early detection of infants at risk of long-term neuromotor disabilities. Gait Posture 2017. [DOI: 10.1016/j.gaitpost.2017.07.079] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 03/25/2023]
|
9
|
Castellani S, Vitiello G, Selvaggio S, Cammelli D, Maggi E, Di Mario C. P5201Diagnostic yield of color doppler ultrasonography in suspected giant cell arteritis: a clinical, sonographic and positron emission tomography retrospective analysis. Eur Heart J 2017. [DOI: 10.1093/eurheartj/ehx493.p5201] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
10
|
Palterer B, Grandi V, Antiga E, Maio V, Maggi E, Liotta F. Cutaneous leucocytoclastic vasculitis with anti-EJ autoantibodies: mere coincidence or a manifestation of antisynthetase syndrome? Clin Exp Dermatol 2017; 42:345-347. [PMID: 28239883 DOI: 10.1111/ced.13063] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 05/05/2016] [Indexed: 11/27/2022]
Affiliation(s)
- B Palterer
- Department of Clinical and Experimental Medicine, Division of Internal Medicine, University of Florence, Largo Brambilla 3, 50134, Florence, Italy
| | - V Grandi
- Department of Surgery and Translational Medicine, Division of Dermatology, University of Florence, Italy
| | - E Antiga
- Department of Surgery and Translational Medicine, Division of Dermatology, University of Florence, Italy
| | - V Maio
- Department of Human Pathology and Oncology, University of Florence, Florence, Italy
| | - E Maggi
- Department of Clinical and Experimental Medicine, Division of Internal Medicine, University of Florence, Largo Brambilla 3, 50134, Florence, Italy
| | - F Liotta
- Department of Clinical and Experimental Medicine, Division of Internal Medicine, University of Florence, Largo Brambilla 3, 50134, Florence, Italy
| |
Collapse
|
11
|
Jung IH, Kurnicka K, Enache R, Nagy AI, Martins E, Cereda A, Vitiello G, Magda SL, Styczynski G, Lo Iudice F, De Barros Viegas H, Shahab F, Trunina I, Mata Caballero R, De Barros Viegas H, Marques A, Shimoni S, Generati G, Generati G, Bendix Salkvist Jorgensen T, Chen TE, Andrianova A, Fernandez-Golfin C, Corneli MC, Ali M, Seo HS, Kim MJ, Lichodziejewska B, Goliszek S, Dzikowska-Diduch O, Zdonczyk O, Kozlowska M, Kostrubiec M, Ciurzynski M, Palczewski P, Pruszczyk P, Popa E, Coman IM, Badea R, Platon P, Calin A, Beladan CC, Rosca M, Ginghina C, Popescu BA, Jurcut R, Venkateshvaran AI, Sola SC, Govind SC, Dash PK, Lund L, Manouras AI, Merkely B, Magne J, Aboyans V, Boulogne C, Lavergne D, Jaccard A, Mohty D, Casadei F, Spano F, Santambrogio G, Musca F, Belli O, De Chiara B, Bokor D, Giannattasio C, Corradi E, Colombo CA, Moreo A, Vicario ML, Castellani S, Cammelli D, Gallini C, Needleman L, Cruz BK, Maggi E, Marchionni N, Bratu VD, Mincu RI, Mihai CM, Gherghe AM, Florescu M, Cinteza M, Vinereanu D, Sobieraj P, Bielicki P, Krenke R, Szmigielski CA, Petitto M, Ferrone M, Esposito R, Vaccaro A, Buonauro A, Trimarco B, Galderisi M, Mendes L, Dores H, Melo I, Madeira V, Patinha J, Encarnacao C, Ferreia Santos J, Habib F, Soesanto AM, Sedyawan J, Abdurrazak G, Sharykin A, Popova NE, Karelina EV, Telezhnikova ND, Hernandez Jimenez V, Saavedra J, Molina L, Alberca MT, Gorriz J, L Pais J, Pavon I, Navea C, Alonso JJ, Mendes L, Sonia S, Madeira V, Encarnacao C, Patinha J, Melo I, Ferreia Santos J, Cruz I, Joao I, Gomes AC, Caldeira D, Lopes L, Fazendas P, Pereira H, Edri O, Edri O, Schneider N, Schneider N, Abaye N, Abaye N, Goerge J, Goerge J, Gandelman G, Gandelman G, Bandera F, Alfonzetti E, Guazzi M, Bandera F, Villani S, Ferraro O, Alfonzetti E, Guazzi M, Ramberg E, Bhardwaj P, Nepper ML, Binko TS, Olausson M, Fink-Jensen T, Andersen AM, Roland J, Gleerup Fornitz G, Ong K, Suri RM, Enrique-Sarano M, Michelena HI, Burkhart HM, Gillespie SM, Cha S, Mankad SV, Saidova MA, Bolotova MN, Salido Tahoces L, Izurieta C, Villareal G, Esteban A, Urena Vacas A, Ayala A, Jimenez Nacher JJ, Hinojar Baydes R, Gonzalez Gomez A, Garcia A, Mestre JL, Hernandez Antolin R, Zamorano Gomez JJ, Perea G, Covelli Y, Henquin R, Ronderos R, Hepinstall MJ, Cassidy CS, Pellikka PA, Pislaru SV, Kane G. P569Diastolic dyssynchrony is associated with exercise intolerance in hypertensive patients with left ventricular hypertrophyP570Echocardiographic pattern of acute pulmonary embolism, analysis of consecutive 511 patientsP571Clinical significance of ventricular interdependence and left ventricular function in patients with pulmonary hypertension receiving specific vasodilator therapyP572Haemodynamic characteristics and ventricular mechanics in post-capillary and combined pre- and post-capillary pulmonary hypertensionP573Relationship between hematological response and echocardiographic features in patients with light chains systemic amyloidosisP574Myocardial changes in patients with anorexia nervosaP575Giant cell arteritis presenting as fever of unknown origin: role of clinical history, early positron emission tomography and ultrasound screeningP576Subclinical systolic dysfunction in systemic sclerosis is not influenced by standard rheumatologic therapy - a 4D echocardiographic studyP577Cardiac index correlates with the degree of hepatic steathosis in obese patients with obstructive sleep apneaP578Myocardial mechanics in top-level endurance athletes: a three-dimensional speckle tracking studyP579The athlete heart: what happens to myocardial deformation in physiological adaptation to sportsP580Association between left ventricle intrinsic function and urine protein-creatinine ratio in preeclampsia before and after deliveryP581Dilatation of the aorta in children with bicuspid aortic valveP582Cardiovascular functional abnormalities in patients with osteogenesis imperfectaP583Dobutamine stress test fast protocol: diagnostic accuracy and securityP584Prognostic value of non-positive exercise echocardiography in the patients submitted to percutaneous coronary interventionP585The use of myocardial strain imaging in the detection of coronary artery disease during stress echocardiographyP586Preserved O2 extraction exercise response in heart failure patients with chronotropic insufficiency: evidence for a central cardiac rather than peripheral oxygen uptake limitationP587Major determinant of O2 artero-venous difference at peak exercise in heart failure and healthy subjectsP588Stress echocardiography with contrast perfusion analysis for a more sensitive test for ischemic heart diseaseP589Assessment of mitral annular physiology in myxomatous mitral disease with 3D transesophageal echocardiography: comparison between early severe mitral regurgitation and decompensated groupP590Three-dimensional transesophageal echocardiographic assessment of the mitral valve geometry in patients with mild, moderate and severe chronic ischemic mitral regurgitationP591Left atrial appendage closure. Multimodality imaging in device size selectionP592Contributions of three-dimensional transesophageal echocardiography in the evaluation of aortic atherosclerotic plaquesP593Agitated blood-saline is superior to agitated air-saline for echocardiographic shunt studies. Eur Heart J Cardiovasc Imaging 2016; 17:ii102-ii109. [DOI: 10.1093/ehjci/jew248.002] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
12
|
Vultaggio A, Petroni G, Pratesi S, Nencini F, Cammelli D, Milla M, Prignano F, Annese V, Romagnani S, Maggi E, Matucci A. Circulating T cells to infliximab are detectable mainly in treated patients developing anti-drug antibodies and hypersensitivity reactions. Clin Exp Immunol 2016; 186:364-372. [PMID: 27569750 PMCID: PMC5108070 DOI: 10.1111/cei.12858] [Citation(s) in RCA: 27] [Impact Index Per Article: 3.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 08/12/2016] [Indexed: 01/28/2023] Open
Abstract
Antibodies recognizing infliximab (IFX) may develop in a proportion of treated patients, leading to loss of response or hypersensitivity reactions (HRs). T cell response to IFX has been poorly investigated. This paper was addressed to detect IFX‐specific T cells in treated patients with inflammatory diseases developing, or not, anti‐drug antibodies (ADA) and to correlate the presence of specific T cells with the clinical outcomes of the treatment. A co‐culture system of IFX‐loaded dendritic cells and purified autologous CD4+ T cells was used to detect memory T cells in 32 ADA+ and 39 ADA– IFX‐treated patients and control groups. The cytokine profile of IFX‐specific T cells was also studied in culture supernatants. IFX‐specific cell proliferation was detected mainly in cells from ADA+ patients, irrespective of their different diseases. HR patients displayed higher T cell proliferation than non‐responder and tolerant patients. A mixed [interferon (IFN)‐γ, interleukin (IL)‐13, IL‐10] cytokine profile was shown in cells from ADA+ patients, while IL‐10 was the most frequently detected cytokine in the supernatants of cultures from ADA‐ patients. Immunoglobulin (Ig)E+ADA+ patients with previous HRs exhibited a more pronounced type 2 profile than IgE–ADA+ patients. This work provides evidence that IFX‐specific circulating T cells are detectable mainly in ADA+ patients with HRs, regardless of their disease. The IFX‐induced cytokine pattern partially correlates with the ADA isotype.
Collapse
Affiliation(s)
- A Vultaggio
- Centre of Research DENOTHE and Department of Experimental and Clinical Medicine, University of Florence, Italy.,Immunoallergology Unit, Azienda Ospedaliero-Universitaria Careggi, Florence, Italy
| | - G Petroni
- Centre of Research DENOTHE and Department of Experimental and Clinical Medicine, University of Florence, Italy
| | - S Pratesi
- Centre of Research DENOTHE and Department of Experimental and Clinical Medicine, University of Florence, Italy
| | - F Nencini
- Centre of Research DENOTHE and Department of Experimental and Clinical Medicine, University of Florence, Italy
| | - D Cammelli
- Immunoallergology Unit, Azienda Ospedaliero-Universitaria Careggi, Florence, Italy
| | - M Milla
- Gastroenterology Unit, Azienda Ospedaliero-Universitaria Careggi, Florence, Italy
| | - F Prignano
- Dermatology Clinic, Azienda Sanitaria Firenze, Department of Surgery and Translational Medicine, University of Florence, Florence, Italy
| | - V Annese
- Gastroenterology Unit, Azienda Ospedaliero-Universitaria Careggi, Florence, Italy
| | - S Romagnani
- Centre of Research DENOTHE and Department of Experimental and Clinical Medicine, University of Florence, Italy
| | - E Maggi
- Centre of Research DENOTHE and Department of Experimental and Clinical Medicine, University of Florence, Italy
| | - A Matucci
- Centre of Research DENOTHE and Department of Experimental and Clinical Medicine, University of Florence, Italy.,Immunoallergology Unit, Azienda Ospedaliero-Universitaria Careggi, Florence, Italy
| | | |
Collapse
|
13
|
Rup B, Pallardy M, Sikkema D, Albert T, Allez M, Broet P, Carini C, Creeke P, Davidson J, De Vries N, Finco D, Fogdell-Hahn A, Havrdova E, Hincelin-Mery A, C Holland M, H Jensen PE, Jury EC, Kirby H, Kramer D, Lacroix-Desmazes S, Legrand J, Maggi E, Maillère B, Mariette X, Mauri C, Mikol V, Mulleman D, Oldenburg J, Paintaud G, R Pedersen C, Ruperto N, Seitz R, Spindeldreher S, Deisenhammer F. Standardizing terms, definitions and concepts for describing and interpreting unwanted immunogenicity of biopharmaceuticals: recommendations of the Innovative Medicines Initiative ABIRISK consortium. Clin Exp Immunol 2015; 181:385-400. [PMID: 25959571 PMCID: PMC4557374 DOI: 10.1111/cei.12652] [Citation(s) in RCA: 61] [Impact Index Per Article: 6.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 03/23/2015] [Indexed: 12/17/2022] Open
Abstract
Biopharmaceuticals (BPs) represent a rapidly growing class of approved and investigational drug therapies that is contributing significantly to advancing treatment in multiple disease areas, including inflammatory and autoimmune diseases, genetic deficiencies and cancer. Unfortunately, unwanted immunogenic responses to BPs, in particular those affecting clinical safety or efficacy, remain among the most common negative effects associated with this important class of drugs. To manage and reduce risk of unwanted immunogenicity, diverse communities of clinicians, pharmaceutical industry and academic scientists are involved in: interpretation and management of clinical and biological outcomes of BP immunogenicity, improvement of methods for describing, predicting and mitigating immunogenicity risk and elucidation of underlying causes. Collaboration and alignment of efforts across these communities is made difficult due to lack of agreement on concepts, practices and standardized terms and definitions related to immunogenicity. The Innovative Medicines Initiative (IMI; http://www.imi-europe.org), ABIRISK consortium [Anti-Biopharmaceutical (BP) Immunization Prediction and Clinical Relevance to Reduce the Risk; http://www.abirisk.eu] was formed by leading clinicians, academic scientists and EFPIA (European Federation of Pharmaceutical Industries and Associations) members to elucidate underlying causes, improve methods for immunogenicity prediction and mitigation and establish common definitions around terms and concepts related to immunogenicity. These efforts are expected to facilitate broader collaborations and lead to new guidelines for managing immunogenicity. To support alignment, an overview of concepts behind the set of key terms and definitions adopted to date by ABIRISK is provided herein along with a link to access and download the ABIRISK terms and definitions and provide comments (http://www.abirisk.eu/index_t_and_d.asp).
Collapse
Affiliation(s)
- B Rup
- Pfizer, Immunogenicity Sciences Disciple, Pharmacokinetics, Dynamics and Metabolism
| | - M Pallardy
- INSERM, UMR996, Faculté Pharmacie, Université Paris Sud, France
| | - D Sikkema
- GlaxoSmithKline, Clinical Immunology-Biopharm, King of Prussia, PA, USA
| | - T Albert
- Institute of Experimental Haematology and Transfusion Medicine, University Clinic Bonn, Bonn, Germany
| | - M Allez
- Hôpital Saint-Louis, Department of Gastroenterology, GETAID, Paris, France
| | - P Broet
- INSERM, UMR669, University of Paris Sud, France
| | - C Carini
- Pfizer, Early Biotech Clinical Development, Cambridge, MA, USA
| | - P Creeke
- Centre for Neuroscience and Trauma, Blizard Institute, Queen Mary University of London, London, UK
| | - J Davidson
- GlaxoSmithKline, Worldwide Epidemiology, Southall, UK
| | - N De Vries
- Clinical Immunology and Rheumatology, University of Amsterdam, Amsterdam, the Netherlands
| | - D Finco
- Pfizer, Drug Safety R&D, Groton, CT, USA
| | - A Fogdell-Hahn
- Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden
| | - E Havrdova
- Department of Neurology and Center for Clinical Neuroscience, MS Center, Charles University in Prague, Prague, Czech Republic
| | - A Hincelin-Mery
- Sanofi-Aventis, Clinical Exploratory and Pharmacology, Chilly-Mazerin, FR
| | - M C Holland
- GlaxoSmithKline, Clinical Immunology-Biopharm R&D, King of Prussia, PA, USA
| | - P E H Jensen
- Department of Neurology, University of Copenhagen, Copenhagen, Denmark
| | - E C Jury
- Centre for Rheumatology, University College London, London, UK
| | - H Kirby
- UCB Pharma, Bioanalytical R&D, Slough, UK
| | - D Kramer
- Merck-Serono, Institute of Drug Metabolism and Pharmacokinetics, Grafing, Germany
| | | | - J Legrand
- Ipsen Innovation, Pharmacokinetics Drug Metabolism Department, Les Ulis, France
| | - E Maggi
- Dipartimento di Medicina Sperimentale e Clinica, Universita di Firenze, Firenze, Italy
| | - B Maillère
- CEA-Saclay Institute of Biology and Technologies, Gif sur Yvette, France
| | - X Mariette
- INSERM, U1012, Hôpitaux Universitaires Paris Sud, Rhumatologie, Paris, France
| | - C Mauri
- Centre for Rheumatology Research, University College London, London, UK
| | - V Mikol
- Sanofi Aventis, Structural Biology, Paris, France
| | - D Mulleman
- University of Tours Francois Rabelais, CNRS UMR 7292, Tours, France
| | - J Oldenburg
- Institute of Experimental Haematology and Transfusion Medicine, University Clinic Bonn, Bonn, Germany
| | - G Paintaud
- CNRS UMR 7292 'GICC', Faculty of Medicine, Tours, France
| | | | - N Ruperto
- Istituto Giannina Gaslini, Pediatria II, Rheumatology, Genova, Italy
| | - R Seitz
- Division of Haematology/Transfusion Medicine, Paul-Ehrlich-Institut, Langen, Germany
| | - S Spindeldreher
- Drug Metabolism Pharmacokinetics-Biologics, Novartis Institutes for Biomedical Research, Basel, Switzerland
| | - F Deisenhammer
- Department of Neurology, Innsbruck Medical University, Innsbruck, Austria
| | | |
Collapse
|
14
|
Campanini G, Maggi E, Artioli D. Present situation of organochlorine pesticide residues in food of animal origin in Italy. World Rev Nutr Diet 2015; 35:129-71. [PMID: 6156548 DOI: 10.1159/000386409] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/18/2023]
|
15
|
Liotta F, Querci V, Mannelli G, Santarlasci V, Maggi L, Capone M, Rossi MC, Mazzoni A, Cosmi L, Romagnani S, Maggi E, Gallo O, Annunziato F. Mesenchymal stem cells are enriched in head neck squamous cell carcinoma, correlates with tumour size and inhibit T-cell proliferation. Br J Cancer 2015; 112:745-54. [PMID: 25647013 PMCID: PMC4333504 DOI: 10.1038/bjc.2015.15] [Citation(s) in RCA: 48] [Impact Index Per Article: 5.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/06/2014] [Revised: 11/19/2014] [Accepted: 12/22/2014] [Indexed: 12/15/2022] Open
Abstract
BACKGROUND Cancer is a multifactorial disease not only restricted to transformed epithelium, but also involving cells of the immune system and cells of mesenchymal origin, particularly mesenchymal stem cells (MSCs). Mesenchymal stem cells contribute to blood- and lymph- neoangiogenesis, generate myofibroblasts, with pro-invasive activity and may suppress anti-tumour immunity. METHODS In this paper, we evaluated the presence and features of MSCs isolated from human head neck squamous cell carcinoma (HNSCC). RESULTS Fresh specimens of HNSCC showed higher proportions of CD90+ cells compared with normal tissue; these cells co-expressed CD29, CD105, and CD73, but not CD31, CD45, CD133, and human epithelial antigen similarly to bone marrow-derived MSCs (BM-MSCs). Adherent stromal cells isolated from tumour shared also differentiation potential with BM-MSCs, thus we named them as tumour-MSCs. Interestingly, tumour-MSCs showed a clear immunosuppressive activity on in vitro stimulated T lymphocytes, mainly mediated by indoelamine 2,3 dioxygenase activity, like BM-MSCs. To evaluate their possible role in tumour growth in vivo, we correlated tumour-MSC proportions with neoplasm size. Tumour-MSCs frequency directly correlated with tumour volume and inversely with the frequency of tumour-infiltrating leukocytes. CONCLUSIONS These data support the concept that tumour-MSCs may favour tumour growth not only through their effect on stromal development, but also by inhibiting the anti-tumour immune response.
Collapse
Affiliation(s)
- F Liotta
- 1] Department of Experimental and Clinical Medicine and DENOTHE Center, University of Florence, 50134 Florence, Italy [2] Regenerative Medicine Unit and Immunology and Cellular Therapy Unit of Azienda Ospedaliero-Universitaria Careggi, 50134 Florence, Italy
| | - V Querci
- Department of Experimental and Clinical Medicine and DENOTHE Center, University of Florence, 50134 Florence, Italy
| | - G Mannelli
- First Clinic of Otorhinolaryngology, Head and Neck Surgery, University of Florence, Azienda Ospedaliera Universitaria Careggi, 50134 Florence, Italy
| | - V Santarlasci
- Department of Experimental and Clinical Medicine and DENOTHE Center, University of Florence, 50134 Florence, Italy
| | - L Maggi
- Department of Experimental and Clinical Medicine and DENOTHE Center, University of Florence, 50134 Florence, Italy
| | - M Capone
- Department of Experimental and Clinical Medicine and DENOTHE Center, University of Florence, 50134 Florence, Italy
| | - M C Rossi
- Department of Experimental and Clinical Medicine and DENOTHE Center, University of Florence, 50134 Florence, Italy
| | - A Mazzoni
- Department of Experimental and Clinical Medicine and DENOTHE Center, University of Florence, 50134 Florence, Italy
| | - L Cosmi
- 1] Department of Experimental and Clinical Medicine and DENOTHE Center, University of Florence, 50134 Florence, Italy [2] Regenerative Medicine Unit and Immunology and Cellular Therapy Unit of Azienda Ospedaliero-Universitaria Careggi, 50134 Florence, Italy
| | - S Romagnani
- Department of Experimental and Clinical Medicine and DENOTHE Center, University of Florence, 50134 Florence, Italy
| | - E Maggi
- 1] Department of Experimental and Clinical Medicine and DENOTHE Center, University of Florence, 50134 Florence, Italy [2] Regenerative Medicine Unit and Immunology and Cellular Therapy Unit of Azienda Ospedaliero-Universitaria Careggi, 50134 Florence, Italy
| | - O Gallo
- First Clinic of Otorhinolaryngology, Head and Neck Surgery, University of Florence, Azienda Ospedaliera Universitaria Careggi, 50134 Florence, Italy
| | - F Annunziato
- 1] Department of Experimental and Clinical Medicine and DENOTHE Center, University of Florence, 50134 Florence, Italy [2] Regenerative Medicine Unit and Immunology and Cellular Therapy Unit of Azienda Ospedaliero-Universitaria Careggi, 50134 Florence, Italy
| |
Collapse
|
16
|
Goirigolzarri Artaza J, Gallego Delgado M, Jaimes Castellanos C, Cavero Gibanel M, Pastrana Ledesma M, Alonso Pulpon L, Gonzalez Mirelis J, Al Ansi RZ, Sokolovic S, Cerin G, Szychta W, Popa BA, Botezatu D, Benea D, Manganiello S, Corlan A, Jabour A, Igual Munoz B, Osaca Asensi J, Andres La Huerta A, Maceira Gonzalez A, Estornell Erill J, Cano Perez O, Sancho-Tello M, Alonso Fernandez P, Sepulveda Sanchez P, Montero Argudo A, Palombo C, Morizzo C, Baluci M, Kozakova M, Panajotu A, Karady J, Szeplaki G, Horvath T, Tarnoki D, Jermendy A, Geller L, Merkely B, Maurovich-Horvat P, Moustafa S, Mookadam F, Youssef M, Zuhairy H, Connelly M, Prieur T, Alvarez N, Ashikhmin Y, Drapkina O, Boutsikou M, Demerouti E, Leontiadis E, Petrou E, Karatasakis G, Kozakova M, Morizzo C, Bianchi V, Marchi B, Federico G, Palombo C, Chatzistamatiou E, Moustakas G, Memo G, Konstantinidis D, Mpampatzeva Vagena I, Manakos K, Traxanas K, Vergi N, Feretou A, Kallikazaros I, Goto M, Uejima T, Itatani K, Pedrizzetti G, Mada R, Daraban A, Duchenne J, Voigt J, Chiu DYY, Green D, Johnstone L, Sinha S, Kalra P, Abidin N, Sikora-Frac M, Zaborska B, Maciejewski P, Bednarz B, Budaj A, Nemes A, Sasi V, Gavaller H, Kalapos A, Domsik P, Katona A, Szucsborus T, Ungi T, Forster T, Ungi I, Pluchinotta F, Arcidiacono C, Saracino A, Carminati M, Bussadori C, Dahlslett T, Karlsen S, Grenne B, Sjoli B, Bendz B, Skulstad H, Smiseth O, Edvardsen T, Brunvand H, Vereckei A, Szelenyi Z, Szenasi G, Santoro C, Galderisi M, Niglio T, Santoro M, Stabile E, Rapacciuolo A, Spinelli L, De Simone G, Esposito G, Trimarco B, Hubert S, Jacquier A, Fromonot J, Resseguier C, Tessier A, Guieu R, Renard S, Haentjiens J, Lavoute C, Habib G, Menting ME, Koopman L, Mcghie J, Rebel B, Gnanam D, Helbing W, Van Den Bosch A, Roos-Hesselink J, Shiino K, Yamada A, Sugimoto K, Takada K, Takakuwa Y, Miyagi M, Iwase M, Ozaki Y, Hayashi T, Itatani K, Inuzuka R, Shindo T, Hirata Y, Shimizu N, Miyaji K, Henri C, Dulgheru R, Magne J, Kou S, Davin L, Nchimi A, Oury C, Pierard L, Lancellotti P, Kovalyova O, Honchar O, Tengku W, Ketaren A, Mingo Santos S, Monivas Palomero V, Restrepo Cordoba A, Rodriguez Gonzalez E, Goirigolzarri Artaza J, Sayago Silva I, Garcia Lunar I, Mitroi C, Cavero Gibanel M, Segovia Cubero J, Ryu S, Park J, Kim S, Choi J, Goh C, Byun Y, Choi J, Westholm C, Johnson J, Jernberg T, Winter R, Rio P, Moura Branco L, Galrinho A, Pinto Teixeira P, Viveiros Monteiro A, Portugal G, Pereira-Da-Silva T, Afonso Nogueira M, Abreu J, Cruz Ferreira R, Mazzone A, Botto N, Paradossi U, Chabane A, Francini M, Cerone E, Baroni M, Maffei S, Berti S, Ghattas A, Shantsila E, Griffiths H, Lip G, Galli E, Guirette Y, Daudin M, Auffret V, Mabo P, Donal E, Fabiani I, Conte L, Scatena C, Barletta V, Pratali S, De Martino A, Bortolotti U, Naccarato A, Di Bello V, Falanga G, Alati E, Di Giannuario G, Zito C, Cusma' Piccione M, Carerj S, Oreto G, Dattilo G, Alfieri O, La Canna G, Generati G, Bandera F, Pellegrino M, Alfonzetti E, Labate V, Guazzi M, Cengiz B, Sahin ST, Yurdakul S, Kahraman S, Bozkurt A, Aytekin S, Borges IP, Peixoto E, Peixoto R, Peixoto R, Marcolla V, Venkateshvaran A, Sola S, Dash PK, Thapa P, Manouras A, Winter R, Brodin L, Govind SC, Mizariene V, Verseckaite R, Bieseviciene M, Karaliute R, Jonkaitiene R, Vaskelyte J, Arzanauskiene R, Janenaite J, Jurkevicius R, Rosner S, Orban M, Nadjiri J, Lesevic H, Hadamitzky M, Sonne C, Manganaro R, Carerj S, Cusma-Piccione M, Caprino A, Boretti I, Todaro M, Falanga G, Oreto L, D'angelo M, Zito C, Le Tourneau T, Cueff C, Richardson M, Hossein-Foucher C, Fayad G, Roussel J, Trochu J, Vincentelli A, Cavalli G, Muraru D, Miglioranza M, Addetia K, Veronesi F, Cucchini U, Mihaila S, Tadic M, Lang R, Badano L, Polizzi V, Pino P, Luzi G, Bellavia D, Fiorilli R, Chialastri C, Madeo A, Malouf J, Buffa V, Musumeci F, Gripari P, Tamborini G, Bottari V, Maffessanti F, Carminati C, Muratori M, Vignati C, Bartorelli A, Alamanni F, Pepi M, Polymeros S, Dimopoulos A, Spargias K, Karatasakis G, Athanasopoulos G, Pavlides G, Dagres N, Vavouranakis E, Stefanadis C, Cokkinos D, Pradel S, Mohty D, Magne J, Darodes N, Lavergne D, Damy T, Beaufort C, Aboyans V, Jaccard A, Mzoughi K, Zairi I, Jabeur M, Ben Moussa F, Ben Chaabene A, Kamoun S, Mrabet K, Fennira S, Zargouni A, Kraiem S, Jovanova S, Arnaudova-Dezjulovic F, Correia CE, Cruz I, Marques N, Fernandes M, Bento D, Moreira D, Lopes L, Azevedo O, Keramida K, Kouris N, Kostopoulos V, Psarrou G, Giannaris V, Olympios C, Marketou M, Parthenakis F, Kalyva N, Pontikoglou C, Maragkoudakis S, Zacharis E, Patrianakos A, Roufas K, Papadaki H, Vardas P, Dominguez Rodriguez F, Monivas Palomero V, Mingo Santos S, Arribas Rivero B, Cuenca Parra S, Zegri Reiriz I, Vazquez Lopez-Ibor J, Garcia-Pavia P, Szulik M, Streb W, Wozniak A, Lenarczyk R, Sliwinska A, Kalarus Z, Kukulski T, Nemes A, Domsik P, Kalapos A, Forster T, Serra W, Lumetti F, Mozzani F, Del Sante G, Ariani A, Corros C, Colunga S, Garcia-Campos A, Diaz E, Martin M, Rodriguez-Suarez M, Leon V, Fidalgo A, Moris C, De La Hera J, Kylmala MM, Rosengard-Barlund M, Groop PH, Lommi J, Bruin De- Bon H, Bilt Van Der I, Wilde A, Brink Van Den R, Teske A, Rinkel G, Bouma B, Teixeira R, Monteiro R, Garcia J, Silva A, Graca M, Baptista R, Ribeiro M, Cardim N, Goncalves L, Duszanska A, Skoczylas I, Kukulski T, Polonski L, Kalarus Z, Choi JH, Park J, Ahn J, Lee J, Ryu S, Ahn J, Kim D, Lee H, Przewlocka-Kosmala M, Mlynarczyk J, Rojek A, Mysiak A, Kosmala W, Pellissier A, Larochelle E, Krsticevic L, Baron E, Le V, Roy A, Deragon A, Cote M, Garcia D, Tournoux F, Yiangou K, Azina C, Yiangou A, Zitti M, Ioannides M, Ricci F, Dipace G, Aquilani R, Radico F, Cicchitti V, Bianco F, Miniero E, Petrini F, De Caterina R, Gallina S, Jardim Prista Monteiro R, Teixeira R, Garcia J, Baptista R, Ribeiro M, Cardim N, Goncalves L, Chung H, Kim J, Joung B, Uhm J, Pak H, Lee M, Lee K, Ragab A, Abdelwahab A, Yazeed Y, El Naggar W, Spahiu K, Spahiu E, Doko A, Liesting C, Brugts J, Kofflard M, Kitzen J, Boersma E, Levin MD, Coppola C, Piscopo G, Rea D, Maurea C, Caronna A, Capasso I, Maurea N, Azevedo O, Tadeu I, Lourenco M, Portugues J, Pereira V, Lourenco A, Nesukay E, Kovalenko V, Cherniuk S, Danylenko O, Nemes A, Domsik P, Kalapos A, Lengyel C, Varkonyi T, Orosz A, Forster T, Castro M, Abecasis J, Dores H, Madeira S, Horta E, Ribeiras R, Canada M, Andrade M, Mendes M, Morosin M, Piazza R, Leonelli V, Leiballi E, Pecoraro R, Cinello M, Dell' Angela L, Cassin M, Sinagra G, Nicolosi G, Wierzbowska-Drabik K, Hamala P, Kasprzak J, O'driscoll J, Rossato C, Gargallo-Fernandez P, Araco M, Sharma S, Sharma R, Jakus N, Baricevic Z, Ljubas Macek J, Skoric B, Skorak I, Velagic V, Separovic Hanzevacki J, Milicic D, Cikes M, Deljanin Ilic M, Ilic S, Kocic G, Pavlovic R, Stoickov V, Ilic V, Nikolic L, Generati G, Bandera F, Pellegrino M, Alfonzetti E, Labate V, Guazzi M, Labate V, Bandera F, Generati G, Pellegrino M, Donghi V, Alfonzetti E, Guazzi M, Zakarkaite D, Kramena R, Aidietiene S, Janusauskas V, Rucinskas K, Samalavicius R, Norkiene I, Speciali G, Aidietis A, Kemaloglu Oz T, Ozpamuk Karadeniz F, Akyuz S, Unal Dayi S, Esen Zencirci A, Atasoy I, Osken A, Eren M, Fazendas PR, Caldeira D, Stuart B, Cruz I, Rocha Lopes L, Almeida AR, Sousa P, Joao I, Cotrim C, Pereira H, Fazendas PR, Caldeira D, Stuart B, Cruz I, Rocha Lopes L, Almeida AR, Joao I, Cotrim C, Pereira H, Sinem Cakal S, Elif Eroglu E, Baydar O, Beytullah Cakal B, Mehmet Vefik Yazicioglu M, Mustafa Bulut M, Cihan Dundar C, Kursat Tigen K, Birol Ozkan B, Ali Metin Esen A, Yagasaki H, Kawasaki M, Tanaka R, Minatoguchi S, Houle H, Warita S, Ono K, Noda T, Watanabe S, Minatoguchi S, Cho EJ, Park SJ, Lim HJ, Chang SA, Lee SC, Park SW, Cho EJ, Park SJ, Lim HJ, Chang SA, Lee SC, Park SW, Mornos C, Cozma D, Ionac A, Mornos A, Popescu I, Ionescu G, Pescariu S, Melzer L, Faeh-Gunz A, Seifert B, Attenhofer Jost CH, Storve S, Haugen B, Dalen H, Grue J, Samstad S, Torp H, Ferrarotti L, Maggi E, Piccinino C, Sola D, Pastore F, Marino P, Ranjbar S, Karvandi M, Hassantash S, Karvandi M, Ranjbar S, Tierens S, Remory I, Bala G, Gillis K, Hernot S, Droogmans S, Cosyns B, Lahoutte T, Tran N, Poelaert J, Al-Mallah M, Alsaileek A, Nour K, Celeng C, Horvath T, Kolossvary M, Karolyi M, Panajotu A, Kitslaar P, Merkely B, Maurovich Horvat P, Aguiar Rosa S, Ramos R, Marques H, Portugal G, Pereira Da Silva T, Rio P, Afonso Nogueira M, Viveiros Monteiro A, Figueiredo L, Cruz Ferreira R. Poster session 6. Eur Heart J Cardiovasc Imaging 2014; 15:ii235-ii264. [PMCID: PMC4453635 DOI: 10.1093/ehjci/jeu271] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 08/13/2023] Open
|
17
|
Maggi E, Benedetti‐Cecchi L, Castelli A, Chatzinikolaou E, Crowe TP, Ghedini G, Kotta J, Lyons DA, Ravaglioli C, Rilov G, Rindi L, Bulleri F. Ecological impacts of invading seaweeds: a meta‐analysis of their effects at different trophic levels. DIVERS DISTRIB 2014. [DOI: 10.1111/ddi.12264] [Citation(s) in RCA: 52] [Impact Index Per Article: 5.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022] Open
Affiliation(s)
- E. Maggi
- Dipartimento di Biologia University of Pisa CoNISMa Pisa Italy
| | | | - A. Castelli
- Dipartimento di Biologia University of Pisa CoNISMa Pisa Italy
| | - E. Chatzinikolaou
- Hellenic Centre for Marine Research Institute of Marine Biology Biotechnology and Aquaculture Crete Greece
| | - T. P. Crowe
- School of Biology and Environmental Science University College Dublin Dublin Ireland
| | - G. Ghedini
- Dipartimento di Biologia University of Pisa CoNISMa Pisa Italy
| | - J. Kotta
- Estonian Marine Institute University of Tartu Tallinn Estonia
| | - D. A. Lyons
- School of Biology and Environmental Science University College Dublin Dublin Ireland
| | - C. Ravaglioli
- Dipartimento di Biologia University of Pisa CoNISMa Pisa Italy
| | - G. Rilov
- National Institute of Oceanography Israel Oceanographic and Limnological Research (IOLR) Haifa Israel
| | - L. Rindi
- Dipartimento di Biologia University of Pisa CoNISMa Pisa Italy
| | - F. Bulleri
- Dipartimento di Biologia University of Pisa CoNISMa Pisa Italy
| |
Collapse
|
18
|
Nettis E, Bonifazi F, Bonini S, Di Leo E, Maggi E, Melioli G, Passalacqua G, Senna G, Triggiani M, Vacca A, Canonica GW. Molecular diagnosis and the Italian Board for ISAC. Eur Ann Allergy Clin Immunol 2014; 46:68-73. [PMID: 24739125] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/03/2023]
Abstract
The Component Resolved Diagnostic (CRD) approach has been developed when highly purified or recombinant allergen molecules have become available. These molecules are the allergenic proteins toward which the specific and clinically relevant IgE immune response is directed. So, the identification of protein families and cross-reactivity patterns of importance in allergy have been possible. The Italian advisory BOARD for ISAC was born: to evaluate the advantages, disadvantages and placement in diagnosis of CRD studying its application in allergic patients; to facilitate the interpretation of molecular diagnostics for clinical allergists; to evaluate the effectiveness of CRD in improving diagnostic risk assessment and early preventive treatment of allergic diseases. In the last years, its fields of interest have been: the evaluation of the performance of CRD on multi-sensitized allergic patients with respiratory symptoms and on poly-sensitized athletes; the evolution of IgE repertoire directed to single allergenic components by evaluating allergic patients with different age at a molecular level; the relevance of results obtained using allergen microarray technique for describing the IgE repertoire in allergic patients by reviewing the main articles focused on CRD published in the last 2 years; the need for an educational program focused on this new diagnostic tool also through the creation of an exhaustive and interactive explanation of the laboratory report molecular allergy; the investigation of the performance and potential additional diagnostic values of the ISAC microarray in a real-life clinical setting, taking into account also the economic values.
Collapse
Affiliation(s)
- E Nettis
- Section of Allergy and Clinical Immunology, Dept. of Internal Medicine, University of Bari, Bari, Italy
| | - F Bonifazi
- Allergy Unit, Dept. of Respiratory and Allergic Diseases, Azienda Ospedaliera Umberto I, Torrette, Ancona, Italy
| | - S Bonini
- Institute of Translational Pharmacology, Italian National Research Council, Second University of Naples, Naples, Italy
| | - E Di Leo
- Section of Allergy and Clinical Immunology, Dept. of Internal Medicine, University of Bari, Bari, Italy
| | - E Maggi
- Section of Immunoallergology, University of Florence, Florence, Italy
| | - G Melioli
- Laboratories of Analysis, Istituto Giannina Gaslini, Genoa, Italy
| | - G Passalacqua
- Allergy and Respiratory Diseases, IRCCS IST San Martino, University of Genoa, Genoa, Italy
| | - G Senna
- Allergy Unit, Azienda Ospedale Università, Verona, Italy
| | - M Triggiani
- Immunoallergology Unit, University of Salerno, Salerno, Italy
| | - A Vacca
- Section of Allergy and Clinical Immunology, Dept. of Internal Medicine, University of Bari, Bari, Italy
| | - G W Canonica
- Allergy and Respiratory Diseases, IRCCS IST San Martino, University of Genoa, Genoa, Italy
| |
Collapse
|
19
|
De Nettis E, Bonifazi F, Bonini S, Di Leo E, Maggi E, Melioli G, Passalacqua G, Senna G, Triggiani M, Vacca A, Canonica G. Molecular diagnosis and the Italian Board for ISAC. Eur Ann Allergy Clin Immunol 2014. [DOI: 10.23822/eurannaci.1764-1489.53] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
Affiliation(s)
- E. De Nettis
- Section of Allergy and Clinical Immunology, Dept. of Internal Medicine, University of Bari, Bari, Italy
| | - F. Bonifazi
- Allergy Unit, Dept. of Respiratory and Allergic Diseases, Azienda Ospedaliera Umberto I, Torrette, Ancona, Italy
| | - S. Bonini
- Institute of Translational Pharmacology, Italian National Research Council, Second University of Naples, Naples, Italy
| | - E. Di Leo
- Section of Allergy and Clinical Immunology, Dept. of Internal Medicine, University of Bari, Bari, Italy
- Section of Allergy and Clinical Immunology, Internal Medicine Unit, Ente Ecclesiastico Ospedale F. Miulli, Acquaviva delle Fonti, Bari, Italy
| | - E. Maggi
- Section of Immunoallergology, University of Florence, Florence, Italy
| | - G. Melioli
- Laboratories of Analysis, Istituto Giannina Gaslini, Genoa, Italy
| | - G. Passalacqua
- Allergy and Respiratory Diseases, IRCCS IST San Martino, University of Genoa, Genoa, Italy
| | - G. Senna
- Allergy Unit, Azienda Ospedale Università, Verona, Italy
| | - M. Triggiani
- Immunoallergology Unit, University of Salerno, Salerno, Italy
| | - A. Vacca
- Section of Allergy and Clinical Immunology, Dept. of Internal Medicine, University of Bari, Bari, Italy
| | - G.W. Canonica
- Allergy and Respiratory Diseases, IRCCS IST San Martino, University of Genoa, Genoa, Italy
| |
Collapse
|
20
|
Matucci A, Pratesi S, Petroni G, Nencini F, Virgili G, Milla M, Maggi E, Vultaggio A. Allergological in vitro and in vivo evaluation of patients with hypersensitivity reactions to infliximab. Clin Exp Allergy 2014; 43:659-64. [PMID: 23711128 DOI: 10.1111/cea.12098] [Citation(s) in RCA: 18] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/05/2012] [Revised: 01/31/2013] [Accepted: 02/04/2013] [Indexed: 11/29/2022]
Abstract
BACKGROUND The administration of biological agents is potentially affected by IgE-mediated infusion reactions. OBJECTIVE The aim of the study was to evaluate the utility of skin testing in patients who have experienced infliximab (IFX)-related reactions. METHODS Thirty patients with previous immediate hypersensitivity reaction to IFX, 20 disease-matched non exposed subjects, 15 IFX-treated disease-matched tolerant patients and 15 IFX non-responder patients were enrolled. Non-isotype-specific and IgE anti-drug antibodies (ADAs) were measured by a double-capture ELISA kit and ImmunoCAP assay, respectively. Prick and intra-dermal tests were carried out with the commercial IFX preparation serially diluted. RESULTS Skin testing, performed in 23 of 30 reactive patients, resulted positive in 7 of them (30.4%), whereas no positivity was found in other groups of patients. The majority of reactive patients displayed non-isotype-specific ADAs (23/30, 76.6%) and the presence of anti-IFX IgE antibodies was detected in 6 of them (26%). All 6 IgE-positive reactive patients showed skin testing positivity. One reactive ADAs-positive patient who resulted skin test positive, with no detectable serum IFX-specific IgE ADAs, was also found. Skin testing positivity was associated with severe and early reactions (within the 3rd dose). No unexpected adverse reactions to skin testing were recorded. CONCLUSIONS AND CLINICAL RELEVANCE This study shows that about 30% of reactive patients display skin testing positivity. They usually develop severe reactions, mainly during the first administrations of IFX. The specificity and the safety of skin testing procedure for this biological agent are also confirmed.
Collapse
Affiliation(s)
- A Matucci
- Immunoallergology Unit, Azienda Ospedaliero-Universitaria Careggi, Florence, Italy
| | | | | | | | | | | | | | | |
Collapse
|
21
|
Passalacqua G, Melioli G, Bonifazi F, Bonini S, Maggi E, Senna G, Triggiani M, Nettis E, Rossi RE, Vacca A, Canonica GW. The additional values of microarray allergen assay in the management of polysensitized patients with respiratory allergy. Allergy 2013; 68:1029-33. [PMID: 23889678 DOI: 10.1111/all.12194] [Citation(s) in RCA: 53] [Impact Index Per Article: 4.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 04/30/2013] [Indexed: 12/21/2022]
Abstract
BACKGROUND The IgE response is directed against specific components from an allergenic source. The traditional diagnostic methods use whole extracts, containing allergenic, nonallergenic and cross-reactive molecules. This may pose diagnostic challenges in polysensitized patients. Microarray techniques detect specific IgE against multiple molecules, but their value in term of additional information and economic saving has not been yet defined. OBJECTIVE We assessed the additional diagnostic information provided by an allergen microarray in a large population of polysensitized subjects. METHODS In this multicentre study, allergists were required to carefully record diagnosis and treatment of consecutive patients referred for asthma/rhinitis, using the standard methodology (history, skin prick test, IgE assay). Then, a microarray allergen assay was carried out. Clinicians were required to review their diagnosis/treatment according to microarray results. RESULTS 318 allergic patients (30% reporting also nonrespiratory symptoms) and 91 controls were enrolled. The clinicians reported at least one additional information from the microarray in about 60% of patients, this resulting in therapeutic adjustments. In 66% of patients IgE to pan-allergens were detectable, being this clinically relevant in 38% of patients with polysensitization to pollens. CONCLUSION Microarray IgE assay represents an advancement in allergy diagnosis, as a third-level approach in polysensitized subjects, when the traditional diagnosis may be problematic.
Collapse
Affiliation(s)
- G. Passalacqua
- Allergy and Respiratory Diseases; IRCCS San Martino Hospital-University of Genoa-IST; Genoa; Italy
| | - G. Melioli
- Laboratorio Centrale di Analisi; Istituto Giannina Gaslini; Genoa; Italy
| | - F. Bonifazi
- Department of Respiratory and Allergic Diseases; Allergy Unit; Azienda Ospedaliera Umberto I; Ancona; Italy
| | - S. Bonini
- Institute of Translational Pharmacology; Italian National Research Council; Second University of Naples; Naples; Italy
| | - E. Maggi
- Section of Immunoallergology; University of Florence; Florence; Italy
| | - G. Senna
- Allergy Unit; Azienda Ospedale Università; Verona; Italy
| | - M. Triggiani
- Immunoallergology Unit; University of Salerno; Salerno; Italy
| | - E. Nettis
- Department of Internal Medicine; Section of Allergy and Clinical Immunology; University of Bari; Bari; Italy
| | - R. E. Rossi
- Rete di Allergologia Regione Piemonte; Azienda Sanitaria Cuneo 1; Cuneo; Italy
| | - A. Vacca
- Department of Internal Medicine; Section of Allergy and Clinical Immunology; University of Bari; Bari; Italy
| | - G. W. Canonica
- Allergy and Respiratory Diseases; IRCCS San Martino Hospital-University of Genoa-IST; Genoa; Italy
| | | |
Collapse
|
22
|
Gandhi G, Allahbadia G, Kagalwala S, Allahbadia A, Ramesh S, Patel K, Hinduja R, Chipkar V, Madne M, Ramani R, Joo JK, Jeung JE, Go KR, Lee KS, Goto H, Hashimoto S, Amo A, Yamochi T, Iwata H, Morimoto Y, Koifman M, Lahav-Baratz S, Blais E, Megnazi-Wiener Z, Ishai D, Auslender R, Dirnfeld M, Zaletova V, Zakharova E, Krivokharchenko I, Zaletov S, Zhu L, Li Y, Zhang H, Ai J, Jin L, Zhang X, Rajan N, Kovacs A, Foley C, Flanagan J, O'Callaghan J, Waterstone J, Dineen T, Dahdouh EM, St-Michel P, Granger L, Carranza-Mamane B, Faruqi F, Kattygnarath TV, Gomes FLAF, Christoforidis N, Ioakimidou C, Papas C, Moisidou M, Chatziparasidou A, Klaver M, Tilleman K, De Sutter P, Lammers J, Freour T, Splingart C, Barriere P, Ikeno T, Nakajyo Y, Sato Y, Hirata K, Kyoya T, Kyono K, Campos FB, Meseguer M, Nogales M, Martinez E, Ariza M, Agudo D, Rodrigo L, Garcia-Velasco JA, Lopes AS, Frederickx V, Vankerkhoven G, Serneels A, Roziers P, Puttermans P, Campo R, Gordts S, Fragouli E, Alfarawati S, Spath K, Wells D, Liss J, Lukaszuk K, Glowacka J, Bruszczynska A, Gallego SC, Lopez LO, Vila EO, Garcia MG, Canas CL, Segovia AG, Ponce AG, Calonge RN, Peregrin PC, Hashimoto S, Amo A, Ito K, Nakaoka Y, Morimoto Y, Alcoba DD, Valerio EG, Conzatti M, Tornquist J, Kussler AP, Pimentel AM, Corleta HE, Brum IS, Boyer P, Montjean D, Tourame P, Gervoise-Boyer M, Cohen J, Lefevre B, Radio CI, Wolf JP, Ziyyat A, De Croo I, Tolpe A, Degheselle S, Van de Velde A, Tilleman K, De Sutter P, Van den Abbeel E, Kagalwala S, Gandhi G, Allahbadia G, Kuwayama M, Allahbadia A, Chipkar V, Khatoon A, Ramani R, Madne M, Alsule S, Inaba M, Ohgaki A, Ohtani A, Matsumoto H, Mizuno S, Mori R, Fukuda A, Morimoto Y, Umekawa Y, Yoshida A, Tanigiwa S, Seida K, Suzuki H, Tanaka M, Vahabi Z, Yazdi PE, Dalman A, Ebrahimi B, Mostafaei F, Niknam MR, Watanabe S, Kamihata M, Tanaka T, Matsunaga R, Yamanaka N, Kani C, Ishikawa T, Wada T, Morita H, Miyamura H, Nishio E, Ito M, Kuwahata A, Ochi M, Horiuchi T, Dal Canto M, Guglielmo MC, Fadini R, Renzini MM, Albertini DF, Novara P, Lain M, Brambillasca F, Turchi D, Sottocornola M, Coticchio G, Kato M, Fukunaga N, Nagai R, Kitasaka H, Yoshimura T, Tamura F, Hasegawa N, Nakayama K, Takeuchi M, Ohno H, Aoyagi N, Kojima E, Itoi F, Hashiba Y, Asada Y, Kikuchi H, Iwasa Y, Kamono T, Suzuki A, Yamada K, Kanno H, Sasaki K, Murakawa H, Matsubara M, Yoshida H, Valdespin C, Elhelaly M, Chen P, Pangestu M, Catt S, Hojnik N, Kovacic B, Roglic P, Taborin M, Zafosnik M, Knez J, Vlaisavljevic V, Mori C, Yabuuchi A, Ezoe K, Takayama Y, Aono F, Kato K, Radwan P, Krasinski R, Chorobik K, Radwan M, Stoppa M, Maggiulli R, Capalbo A, Ievoli E, Dovere L, Scarica C, Albricci L, Romano S, Sanges F, Barnocchi N, Papini L, Vivarelli A, Ubaldi FM, Rienzi L, Rienzi L, Bono S, Capalbo A, Spizzichino L, Rubio C, Ubaldi FM, Fiorentino F, Ferris J, Favetta LA, MacLusky N, King WA, Madani T, Jahangiri N, Aflatoonian R, Cater E, Hulme D, Berrisford K, Jenner L, Campbell A, Fishel S, Zhang XY, Yilmaz A, Hananel H, Ao A, Vutyavanich T, Piromlertamorn W, Saenganan U, Samchimchom S, Wirleitner B, Lejeune B, Zech NH, Vanderzwalmen P, Albani E, Parini V, Smeraldi A, Menduni F, Antonacci R, Marras A, Levi S, Morreale G, Pisano B, Di Biase A, Di Rosa A, Setti PEL, Puard V, Cadoret V, Tranchant T, Gauthier C, Reiter E, Guerif F, Royere D, Yoon SY, Eum JH, Park EA, Kim TY, Yoon TK, Lee DR, Lee WS, Cabal AC, Vallejo B, Campos P, Sanchez E, Serrano J, Remohi J, Nagornyy V, Mazur P, Mykytenko D, Semeniuk L, Zukin V, Guilherme P, Madaschi C, Bonetti TCS, Fassolas G, Izzo CR, Santos MJDL, Beltran D, Garcia-Laez V, Escriba MJ, Grau N, Escrich L, Albert C, Zuzuarregui JL, Pellicer A, LU Y, Nikiforaki D, Meerschaut FV, Neupane J, De Vos WH, Lierman S, Deroo T, Heindryckx B, De Sutter P, Li J, Chen XY, Lin G, Huang GN, Sun ZY, Zhong Y, Zhang B, Li T, Zhang SP, Ye H, Han SB, Liu SY, Zhou J, Lu GX, Zhuang GL, Muela L, Roldan M, Gadea B, Martinez M, Perez I, Meseguer M, Munoz M, Castello C, Asensio M, Fernandez P, Farreras A, Rovira S, Capdevila JM, Velilla E, Lopez-Teijon M, Kovacs P, Matyas SZ, Forgacs V, Reichart A, Rarosi F, Bernard A, Torok A, Kaali SG, Sajgo A, Pribenszky CS, Sozen B, Ozturk S, Yaba-Ucar A, Demir N, Gelo N, Stanic P, Hlavati V, ogoric S, Pavicic-Baldani D, prem-Goldtajn M, Radakovic B, Kasum M, Strelec M, Canic T, imunic V, Vrcic H, Ajina M, Negra D, Ben-Ali H, Jallad S, Zidi I, Meddeb S, Bibi M, Khairi H, Saad A, Escrich L, Grau N, Meseguer M, Gamiz P, Viloria T, Escriba MJ, Lima ET, Fernandez MP, Prieto JAA, Varela MO, Kassa D, Munoz EM, Morita H, Watanabe S, Kamihata M, Matsunaga R, Wada T, Kani K, Ishikawa T, Miyamura H, Ito M, Kuwahata A, Ochi M, Horiuchi T, Nor-Ashikin MNK, Norhazlin JMY, Norita S, Wan-Hafizah WJ, Mohd-Fazirul M, Razif D, Hoh BP, Dale S, Cater E, Woodhead G, Jenner L, Fishel S, Andronikou S, Francis G, Tailor S, Vourliotis M, Almeida PA, Krivega M, Van de Velde H, Lee RK, Hwu YM, Lu CH, Li SH, Vaiarelli A, Antonacci R, Smeraldi A, Desgro M, Albani E, Baggiani A, Zannoni E, Setti PEL, Kermavner LB, Klun IV, Pinter B, Vrtacnik-Bokal E, De Paepe C, Cauffman G, Verheyen G, Stoop D, Liebaers I, Van de Velde H, Stecher A, Wirleitner B, Vanderzwalmen P, Zintz M, Neyer A, Bach M, Baramsai B, Schwerda D, Zech NH, Wiener-Megnazi Z, Fridman M, Koifman M, Lahav-Baratz S, Blais I, Auslender R, Dirnfeld M, Akerud H, Lindgren K, Karehed K, Wanggren K, Hreinsson J, Rovira S, Capdevila JM, Freijomil B, Castello C, Farreras A, Fernandez P, Asensio M, Lopez-Teijon M, Velilla E, Weiss A, Neril R, Geslevich J, Beck-Fruchter R, Lavee M, Golan J, Ermoshkin A, Shalev E, Shi W, Zhang S, Zhao W, Xue XIA, Wang MIN, Bai H, Shi J, Smith HL, Shaw L, Kimber S, Brison D, Boumela I, Assou S, Haouzi D, Ahmed OA, Dechaud H, Hamamah S, Dasiman R, Nor-Shahida AR, Wan-Hafizah WJ, Norhazlin JMY, Mohd-Fazirul M, Salina O, Gabriele RAF, Nor-Ashikin MNK, Ben-Yosef D, Shwartz T, Cohen T, Carmon A, Raz NM, Malcov M, Frumkin T, Almog B, Vagman I, Kapustiansky R, Reches A, Azem F, Amit A, Cetinkaya M, Pirkevi C, Yelke H, Kumtepe Y, Atayurt Z, Kahraman S, Risco R, Hebles M, Saa AM, Vilches-Ferron MA, Sanchez-Martin P, Lucena E, Lucena M, Heras MDL, Agirregoikoa JA, Martinez E, Barrenetxea G, De Pablo JL, Lehner A, Pribenszky C, Murber A, Rigo J, Urbancsek J, Fancsovits P, Bano DG, Sanchez-Leon A, Marcos J, Molla M, Amorocho B, Nicolas M, Fernandez L, Landeras J, Adeniyi OA, Ehbish SM, Brison DR, Egashira A, Murakami M, Nagafuchi E, Tanaka K, Tomohara A, Mine C, Otsubo H, Nakashima A, Otsuka M, Yoshioka N, Kuramoto T, Choi D, Yang H, Park JH, Jung JH, Hwang HG, Lee JH, Lee JE, Kang AS, Yoo JH, Kwon HC, Lee SJ, Bang S, Shin H, Lim HJ, Min SH, Yeon JY, Koo DB, Kuwayama M, Higo S, Ruvalcaba L, Kobayashi M, Takeuchi T, Yoshida A, Miwa A, Nagai Y, Momma Y, Takahashi K, Chuko M, Nagai A, Otsuki J, Kim SG, Lee JH, Kim YY, Kim HJ, Park IH, Sun HG, Lee KH, Song HJ, Costa-Borges N, Belles M, Herreros J, Teruel J, Ballesteros A, Pellicer A, Calderon G, Nikiforaki D, Vossaert L, Meerschaut FV, Qian C, Lu Y, Parys JB, De Vos WH, Deforce D, Deroo T, Van den Abbeel E, Leybaert L, Heindryckx B, De Sutter P, Surlan L, Otasevic V, Velickovic K, Golic I, Vucetic M, Stankovic V, Stojnic J, Radunovic N, Tulic I, Korac B, Korac A, Fancsovits P, Pribenszky C, Lehner A, Murber A, Rigo J, Urbancsek J, Elias R, Neri QV, Fields T, Schlegel PN, Rosenwaks Z, Palermo GD, Gilson A, Piront N, Heens B, Vastersaegher C, Vansteenbrugge A, Pauwels PCP, Abdel-Raheem MF, Abdel-Rahman MY, Abdel-Gaffar HM, Sabry M, Kasem H, Rasheed SM, Amin M, Abdelmonem A, Ait-Allah AS, VerMilyea M, Anthony J, Bucci J, Croly S, Coutifaris C, Maggiulli R, Rienzi L, Cimadomo D, Capalbo A, Dusi L, Colamaria S, Baroni E, Giuliani M, Vaiarelli A, Sapienza F, Buffo L, Ubaldi FM, Zivi E, Aizenman E, Barash D, Gibson D, Shufaro Y, Perez M, Aguilar J, Taboas E, Ojeda M, Suarez L, Munoz E, Casciani V, Minasi MG, Scarselli F, Terribile M, Zavaglia D, Colasante A, Franco G, Greco E, Hickman C, Cook C, Gwinnett D, Trew G, Carby A, Lavery S, Asgari L, Paouneskou D, Jayaprakasan K, Maalouf W, Campbell BK, Aguilar J, Taboas E, Perez M, Munoz E, Ojeda M, Remohi J, Rega E, Alteri A, Cotarelo RP, Rubino P, Colicchia A, Giannini P, Devjak R, Papler TB, Tacer KF, Verdenik I, Scarica C, Ubaldi FM, Stoppa M, Maggiulli R, Capalbo A, Ievoli E, Dovere L, Albricci L, Romano S, Sanges F, Vaiarelli A, Iussig B, Gala A, Ferrieres A, Assou S, Vincens C, Bringer-Deutsch S, Brunet C, Hamamah S, Conaghan J, Tan L, Gvakharia M, Ivani K, Chen A, Pera RR, Bowman N, Montgomery S, Best L, Campbell A, Duffy S, Fishel S, Hirata R, Aoi Y, Habara T, Hayashi N, Dinopoulou V, Partsinevelos GA, Bletsa R, Mavrogianni D, Anagnostou E, Stefanidis K, Drakakis P, Loutradis D, Hernandez J, Leon CL, Puopolo M, Palumbo A, Atig F, Kerkeni A, Saad A, Ajina M, D'Ommar G, Herrera AK, Lozano L, Majerfeld M, Ye Z, Zaninovic N, Clarke R, Bodine R, Rosenwaks Z, Mazur P, Nagorny V, Mykytenko D, Semeniuk L, Zukin V, Zabala A, Pessino T, Outeda S, Blanco L, Leocata F, Asch R, Wan-Hafizah WJ, Rajikin MH, Nuraliza AS, Mohd-Fazirul M, Norhazlin JMY, Razif D, Nor-Ashikin MNK, Machac S, Hubinka V, Larman M, Koudelka M, Budak TP, Membrado OO, Martinez ES, Wilson P, McClure A, Nargund G, Raso D, Insua MF, Lotti B, Giordana S, Baldi C, Barattini J, Cogorno M, Peri NF, Neuspiller F, Resta S, Filannino A, Maggi E, Cafueri G, Ferraretti AP, Magli MC, Gianaroli L, Sioga A, Oikonomou Z, Chatzimeletiou K, Oikonomou L, Kolibianakis E, Tarlatzis BC, Sarkar MR, Ray D, Bhattacharya J, Alises JM, Gumbao D, Sanchez-Leon A, Amorocho B, Molla M, Nicolas M, Fernandez L, Landeras J, Duffy S, Campbell A, Montgomery S, Hickman CFL, Fishel S, Fiorentino I, Gualtieri R, Barbato V, Braun S, Mollo V, Netti P, Talevi R, Bayram A, Findikli N, Serdarogullari M, Sahin O, Ulug U, Tosun SB, Bahceci M, Leon AS, Gumbao D, Marcos J, Molla M, Amorocho B, Nicolas M, Fernandez L, Landeras J, Cardoso MCA, Aguiar APS, Sartorio C, Evangelista A, Gallo-Sa P, Erthal-Martins MC, Mantikou E, Jonker MJ, de Jong M, Wong KM, van Montfoort APA, Breit TM, Repping S, Mastenbroek S, Power E, Montgomery S, Duffy S, Jordan K, Campbell A, Fishel S, Findikli N, Aksoy T, Gultomruk M, Aktan A, Goktas C, Ulug U, Bahceci M, Petracco R, Okada L, Azambuja R, Badalotti F, Michelon J, Reig V, Kvitko D, Tagliani-Ribeiro A, Badalotti M, Petracco A, Pirkevi C, Cetinkaya M, Yelke H, Kumtepe Y, Atayurt Z, Kahraman S, Aydin B, Cepni I, Serdarogullari M, Findikli N, Bayram A, Goktas C, Sahin O, Ulug U, Bahceci M, Rodriguez-Arnedo D, Ten J, Guerrero J, Ochando I, Perez M, Bernabeu R, Okada L, Petracco R, Azambuja R, Badalotti F, Michelon J, Reig V, Tagliani-Ribeiro A, Kvitko D, Badalotti M, Petracco A, Reig V, Kvitko D, Tagliani-Ribeiro A, Okada L, Azambuja R, Petracco R, Michelon J, Badalotti F, Petracco A, Badalotti M. Embryology. Hum Reprod 2013. [DOI: 10.1093/humrep/det210] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
23
|
Bartoli F, Fiori G, Galluccio F, Petroni G, Pratesi S, Matucci A, Vultaggio A, Nacci F, Nencini F, Maggi E, Matucci-Cerinic M. SAT0129 Incidence and clinical outcome of anti-drug antibodies in infliximab-treated patients. Ann Rheum Dis 2013. [DOI: 10.1136/annrheumdis-2012-eular.3076] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
24
|
Piccinni MP, Lombardelli L, Logiodice F, Tesi D, Kullolli O, Biagiotti R, Giudizi M, Romagnani S, Maggi E, Ficarra G. Potential pathogenetic role of Th17, Th0, and Th2 cells in erosive and reticular oral lichen planus. Oral Dis 2013; 20:212-8. [PMID: 23556506 DOI: 10.1111/odi.12094] [Citation(s) in RCA: 52] [Impact Index Per Article: 4.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/12/2013] [Revised: 02/15/2013] [Accepted: 02/27/2013] [Indexed: 12/28/2022]
Abstract
OBJECTIVES The role of Th17 cells and associated cytokines was investigated in oral lichen planus. MATERIAL AND METHODS 14 consecutive patients with oral lichen planus were investigated. For biological studies, tissues were taken from reticular or erosive lesions and from normal oral mucosa (controls) of the same patient. mRNA expression for IL-17F, IL-17A, MCP-1, IL-13, IL-2, IL-10, IL-1β, RANTES, IL-4, IL-12B, IL-8, IFN-γ, TNF-α, IL-1α, IL-18, TGF-β1, IL-23R, IL-7, IL-15, IL-6, MIG, IP-10, LTB, VEGF, IL-5, IL-27, IL-23A, GAPDH, PPIB, Foxp3, GATA3, and RORC was measured using the QuantiGene 2.0. RESULTS Results showed that Th17-type and Th0-type molecules' mRNAs, when compared with results obtained from tissue controls, were increased in biopsies of erosive lesions, whereas Th2-type molecules' mRNAs were increased in reticular lesions. When the CD4+ T-cell clones, derived from oral lichen planus tissues and tissue controls, were analyzed, a higher prevalence of Th17 (confirmed by an increased CD161 expression) and Th0 CD4+ T clones was found in erosive lesions, whereas a prevalence of Th2 clones was observed in reticular lesions. CONCLUSIONS Our data suggest that Th17, Th0, and Th2 cells, respectively, may have a role in the pathogenesis of erosive and reticular oral lichen planus.
Collapse
Affiliation(s)
- M-P Piccinni
- Department of Experimental and Clinical Medicine, Center of Excellence DENOTHE, University of Florence, Florence, Italy
| | | | | | | | | | | | | | | | | | | |
Collapse
|
25
|
Becherucci V, Gori V, Filì L, Cardilicchia E, Piccini L, Manuelli C, Brugnolo F, Maggi E, Dominici M, Parronchi P, Bambi F. Fibroblast growth factor 2 exerts different unexpected effects on bone marrow-derived human mesenchymal stromal cells. Cytotherapy 2013. [DOI: 10.1016/j.jcyt.2013.01.055] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
26
|
Vultaggio A, Nencini F, Pratesi S, Petroni G, Romagnani S, Maggi E. Poly(I:C) promotes the production of IL-17A by murine CD1d-driven invariant NKT cells in airway inflammation. Allergy 2012; 67:1223-32. [PMID: 22882449 DOI: 10.1111/j.1398-9995.2012.02876.x] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 06/19/2012] [Indexed: 01/08/2023]
Affiliation(s)
- A. Vultaggio
- Immunoallergology Unit; Azienda Ospedaliero-Universitaria Careggi; University of Florence; Florence; Italy
| | | | | | | | | | | |
Collapse
|
27
|
Vultaggio A, Nencini F, Pratesi S, Petroni G, Romagnani S, Maggi E. Poly(I:C) promotes the production of IL-17A by murine CD1d-driven invariant NKT cells in airway inflammation. Allergy 2012. [PMID: 22882449 DOI: 10.1111/j.1398-9995.2012.02876.x.] [Citation(s) in RCA: 14] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Abstract
BACKGROUND IL-17A is associated with different asthma phenotypes as virus-associated or steroid-resistant asthma. Invariant natural killer T (iNKT) cells play an important role in the pathogenesis of asthma. The aim of the study was to evaluate the activity of polyinosinic-polycytidylic acid [poly(I:C)] on IL-17A production by CD1d-activated iNKT cells. METHODS We analysed the in vitro effect of poly(I:C) on the release of IL-17A by spleen and lung CD1d-activated iNKT cells with α-galactosylceramide (α-GalCer). Its activity was also investigated in an α-GalCer-induced murine models, including lung inflammation. The inhibition of IL-17A by Toll-like receptor (TLR) 7 agonists in the same in vitro and in vivo models has been analysed. RESULTS Poly(I:C) upregulated the in vitro IL-17A production by CD1d-activated NK1.1- CD4- iNKT subset, without modifying type 1 and type 2 cytokines. The two stimuli selectively upregulated IL-17A serum levels in vivo. Their intratracheal administration resulted in increased airway hyper-reactivity (AHR), neutrophilia in bronchoalveolar lavage and airway inflammation, which were inhibited by anti-IL-17A antibody. Poly(I:C) effects were attributable to IL1β and IL-23 release from dendritic cells, as showed by inhibition with neutralizing antibodies. TLR7 agonists inhibited the IL-17A production by poly(I:C) plus α-GalCer in the same models. Such effect was associated with the increased production by DC of IL-17A-inhibiting cytokines and the dampening of IL-1β and IL-23. CONCLUSIONS Synthetic dsRNA selectively expand a CD1d-driven IL-17A-producing iNKT cell subset, thus explaining the worsening of airway inflammation by some viral infections. TLR3- and TLR7-triggering viral sequences can exert variable and opposite effects on adaptive immune response.
Collapse
Affiliation(s)
- A Vultaggio
- Immunoallergology Unit, Azienda Ospedaliero-Universitaria Careggi, University of Florence, Florence, Italy
| | | | | | | | | | | |
Collapse
|
28
|
Bulleri F, Benedetti-Cecchi L, Cusson M, Maggi E, Arenas F, Aspden R, Bertocci I, Crowe TP, Davoult D, Eriksson BK, Fraschetti S, Golléty C, Griffin JN, Jenkins SR, Kotta J, Kraufvelin P, Molis M, Pinto IS, Terlizzi A, Valdivia N, Paterson DM. Temporal stability of European rocky shore assemblages: variation across a latitudinal gradient and the role of habitat-formers. OIKOS 2012. [DOI: 10.1111/j.1600-0706.2011.19967.x] [Citation(s) in RCA: 49] [Impact Index Per Article: 4.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
29
|
Maggi L, Cosmi L, Cimaz R, Santarlasci V, Capone M, Querci V, Liotta F, Palma R, Maggi E, Romagnani S, Annunziato F. PS1-012. Evidence of a Transient Nature of the th17 Phenotype of cd4+cd161+ t Cells in the Synovial Fluid From Patients with Juvenile Idiopathic Arthritis. Cytokine 2011. [DOI: 10.1016/j.cyto.2011.07.071] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/17/2022]
|
30
|
Abstract
Understanding how species interactions drive succession is a key issue in ecology. In this study we show the utility of combining the concepts and methodologies developed within the biodiversity-ecosystem functioning research program with J. H. Connell and R. O. Slatyer's classic framework to understand succession in assemblages where multiple interactions between early and late colonists may include both inhibitory and facilitative effects. We assessed the net effect of multiple species interactions on successional changes by manipulating the richness, composition, and abundance of early colonists in a low-shore assemblage of algae and invertebrates of the northwestern Mediterranean. Results revealed how concomitant changes in species richness and abundance can strongly alter the net effect of inhibitory vs. facilitative interactions on succession. Increasing richness of early colonists inhibited succession, but only under high levels of initial abundance, probably reflecting the formation of a highly intricate matrix that prevented further colonization. In contrast, increasing initial abundance of early colonists tended to facilitate succession under low richness. Thus, changes in abundance of early colonists mediated the effects of richness on succession.
Collapse
Affiliation(s)
- E Maggi
- Dipartimento di Biologia, University of Pisa, CoNISMa, via Derna 1, Pisa 1-56126, Italy.
| | | | | | | |
Collapse
|
31
|
Abstract
CD4+ T effector lymphocytes are distinguished in different subsets on the basis of their patterns of cytokine secretion. Th1 cells, thank to IFN-γ production, are responsible for cell-mediated immunity against intracellular pathogens, Th2 cells, through the production of IL-4, provide some degree of protection against helminthes, and Th17 cells, via IL-17, promote neutrophils recruitment for the clearance of bacteria and fungi. However, beyond their protective role, these T-helper subsets can also be involved in the pathogenesis of several inflammatory diseases. Asthma is an inflammatory disease characterized by different clinical phenotypes. Allergic asthma is the result of an inflammatory process driven by allergen-specific Th2 lymphocytes, whereas Th17 cells are mainly involved in those forms of asthma, where neutrophils more than eosinophils, contribute to the inflammation. The identification in allergic asthma of Th17/Th2 cells, able to produce both IL-4 and IL-17, is in keeping with the observation that different clinical phenotypes can coexist in the same patient. In conclusion, a picture in which different T-cell subpopulations are active in different phase of bronchial asthma is emerging, and the wide spectrum of clinical phenotypes is probably the expression of different cellular characters playing a role in lung inflammation.
Collapse
Affiliation(s)
- L Cosmi
- Center of Excellence for Research, Transfer of Research and High Education for the Development of Novel therapies, University of Florence, Florence, Italy
| | | | | | | | | |
Collapse
|
32
|
Fassio F, Giudizi M, Biagiotti R, Allegro E, Maggi E, de Martino M, Almerigogna F. Natural Killer Cell Deficiencies In Children With Herpetic Encephalitis - A Case Series. J Allergy Clin Immunol 2011. [DOI: 10.1016/j.jaci.2010.12.067] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
33
|
Romagnani S, Annunziato F, Cosmi L, Liotta F, Maggi E. Human Th17 cells (LL1-7). Int Immunol 2010. [DOI: 10.1093/intimm/dxq073] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
34
|
Versieren K, Heindryckx B, Qian C, Gerris J, De Sutter P, Exposito Navarro A, Ametzazurra A, Nagore D, Crisol L, Aspichueta F, Mendoza R, Matorras R, Garcia MM, Valley JK, Swinton PS, Boscardin WJ, Lue TF, P. Rinaudo, Wu MC, Bern O, Strassburger D, Komarovsky D, Kasterstein E, Komsky A, Maslansky B, Raziel A, Friedler S, Gidoni Y, Ron-El R, Tang J, Fang C, Zhang MF, Li T, Zhuang GL, Suh DS, Joo JK, Choi JR, Kim SC, JO MS, Kim KH, Lee KS, Katz-Jaffe MG, Stevens J, McCormick S, Smith R, Schoolcraft WB, Ben-Ami I, Komsky A, Strassburger D, Bern O, Komarovsky D, Kasterstein E, Maslansky B, Raziel A, Friedler S, Gidoni Y, Ron-El R, Koch J, Costello M, Kilani S, Namm A, Arend A, Aunapuu M, Joo JK, Lee KS, Choi YM, Cho JD, Sipe C, Pelts EJ, Matthews JM, Sanchez SR, Brohammer RLB, Wagner Y, Liebermann J, Uhler M, Beltsos A, Chen MJ, Guu HF, Chen YF, Yih YJ, Ho JYP, Lin TY, Ho ESC, Lopes FB, Figueira RCS, Braga DPAF, Ferreira RC, Aoki T, Iaconelli A, Borges E, Van de Velde H, Cauffman G, Verloes A, De Paepe C, Sterckx J, Van Ranst H, Devroey P, Tournaye H, Liebaers I, Santos MA, Teklenburg G, Macklon NS, Van Opstal D, Schuring-Blom GH, Krijtenburg PJ, de Vreeden-Elbertse J, Fauser BC, Baart EB, Cawood S, Doshi A, Gotts S, Serhal P, Milachich T, Petkova L, Barov D, Shterev A, Esteves TC, Balbach ST, Arauzo-Bravo MJ, Pfeiffer MJ, Boiani M, Le Gac S, van Rossem F, Esteves T, Bioani M, van den Berg A, Valeri C, Pappalardo S, De Felici M, Manna C, Ryu H, Park CY, Min SH, Choi SK, Park C, Lee SH, Kim KR, Jeong H, Chi HJ, Wittemer C, Celebi C, Viville S, Luceno Maestre F, Castilla Alcala JA, Gomez-Palomares JL, Cabello Y, Hernandez J, Marqueta J, Herrero J, Vidal E, Fernandez-Shaw S, Coroleu B, McRae C, Baskind E, Sharma V, Fisher J, Boldi Cotti P, Colasante C, Perego L, De Lauretis L, Montag M, Koster M, Nikolov A, van der Ven H, Lee SG, Lee YC, Kang SM, Kang YJ, Shin YK, Jung JH, Lim JH, Dorfmann A, Carroll K, Sisson M, Geltinger M, Yap S, Iwaszko M, Hara T, Naruse K, Matsuura K, Kodama T, Sato K, Tateaki Y, Tanaka J, Minasi MG, Scarselli F, Rubino P, Casciani V, Colasante A, Lobascio M, Alviggi E, Ferrero S, Litwicka K, Iammarrone E, Cucinelli F, Giannini PG, Tocci A, Nagy ZP, Greco E, Borini A, Tarozzi N, Fiorentin D, Bonu MA, Nadalini M, Johnson J, De Santis L, Bianchi V, Casciani V, Rubino P, Minasi MG, Colasante A, Scarselli F, Lobascio AM, Arizzi L, Iammarrone E, Litwicka K, Ferrero S, Tocci A, Piscitelli C, Cucinelli F, Nagy ZP, Greco E, Mesut N, Ciray HN, Mesut A, Aksoy T, Bahceci M, Lee YM, Chen HW, Wu P, Tzeng CR, Antonova I, Milachich T, Petkova L, Yunakova M, Chaveeva P, A. Shterev, Hlinka D, Dudas M, Rutarova J, Rezacova J, Lazarovska S, Aoi Y, Takahashi H, Saitou H, Takiue C, Kawakami N, Tone M, Hirata R, Terada S, Yoshioka N, Habara T, Hayashi N, Montagut J, Bonald F, Guillen N, Guitard V, Balu-Genvrin E, Crae E, Nogueira D, Silva J, Cunha M, Viana P, Teixeira da Silva JM, Oliveira C, Goncalves A, Barros N, Sousa M, Barros A, van de Werken C, Jahr H, Laven JSE, Baart EB, Gamiz Izquierdo P, De los Santos JM, Tejera A, Pellicer A, Romero JL, Galan A, Albert C, Santos MJDL, Adriaenssens T, Wathlet S, Segers I, Verheyen G, Van De Velde H, Coucke W, Devroey P, Smitz J, Paternot G, D'Hooghe TM, Debrock S, Spiessens C, Hwang HK, Kim HM, Lee JH, Jung YJ, Kang A, Kook MJ, Jung JY, An SJ, Kwon HC, Lee SJ, Somova O, Feskov A, Feskova I, Chumakova N, Zozulina O, Zhilkova YE, Binda M, Campo R, Van Kerkhoven G, Frederickx V, Serneels A, Roziers P, Vranken I, Lopes AS, Van Nuland A, Gordts S, Puttemans P, Valkenburg M, Gordts S, Rodriguez-Arnedo A, Ten J, Guerrero J, Lledo B, Carracedo MA, Ortiz JA, Llacer J, Bernabeu R, Usui K, Nakajo Y, Ota M, Hattori H, Kyoya T, Takisawa T, Kyono K, Ferrieres A, Poulain M, Loup V, Anahory T, Dechaud H, Hamamah S, Eckert J, Premkumar G, Lock F, Brooks S, Haque S, Cameron IT, Cheong Y, Fleming TP, Prados N, Ruiz M, Garcia-Ortega J, Vime P, Hernaez MJ, Crespo M, Fernandez-Sanchez M, Pellicer A, Hashimoto S, Kato N, Saeki K, Morimoto Y, Leung CON, Pang RTK, Liu WM, Lee KF, Yeung WSB, Wada T, Elliott T, Kahn J, Lowderman J, Wright G, Chang C, Bernal D, Kort H, Nagy Z, de los Santos JM, Escrich L, Grau N, Pellicer A, Romero JL, Escriba MJ, Escriba M, Grau N, Escrich L, de los Santos JM, Pellicer A, Romero JL, Tasker F, Hamoda H, Wilner H, Grace J, Khalaf Y, Miyaji S, Mizuno S, Horiuchi L, Haruki A, Fukuda A, Morimoto Y, Utsunomiya T, Kumasako Y, Ito H, Goto K, Koike M, Abe H, Sakamoto T, Kojima F, Koshika T, Muzii L, Magli MC, Gioia L, Scaravelli G, Ferraretti AP, Gianaroli L, Capoti A, Magli MC, Lappi M, Maggi E, Ferraretti AP, Gianaroli L, Scott L, Finn A, Kloos B, Davies D, Yamada M, Hamatani T, Akutsu H, Chikazawa N, Ogawa S, Okumura N, Mochimaru Y, Kuji N, Aoki D, Yoshimura Y, Umezawa A, Aprysko VP, Yakovenko SA, Seregina EA, Yutkin EV, Yelke H, Milik S, Candan ZN, Altin G, Unal S, Atayurt Z, Y. Kumtepe, Chung JT, Son WY, Zhang X, Tan SL, Ao A, Seli E, Botros L, Henson M, Roos P, Judge K, Sakkas D, group MSGMS, Feliciano M, Monahan D, Ermolovich E, Rosenwaks Z, Palermo GD, Mantikou E, van Echten-Arends J, Sikkema-Raddatz B, van der Veen F, Repping S, Mastenbroek S, Botros L, Seli E, Henson M, Roos P, Judge K, Sakkas D, Group MBS, Wells V, Thum MY, Abdalla HI, Machiya R, Akimoto S, Nobuyoshi T, Yoshii N, Hosaka T, Odawara Y, Heindryckx B, Vanden Meerschaut F, Lierman S, Qian C, O'Leary T, Gerris J, De Sutter P, Assou S, Haouzi D, Pellestor F, Monzo C, Dechaud H, De Vos J, Hamamah S, Conaghan J, Fischer E, Popwell J, Ryan I, Chenette P, Givens C, Schriock E, Herbert C, Ermolovich E, Monahan D, Neri QV, Rosenwaks Z, Palermo GD, Verheyen G, Camus M, Van de Velde H, Haentjens P, Devroey P, Mugica A, Esbert M, Molina JM, Garrido N, Pellicer A, Ballesteros A, Calderon G, Rossi ALS, Rocha AM, Alegretti JR, Hassun PA, Gomes LP, Criscuollo T, Serafini P, Motta ELA, Munoz M, Meseguer M, Cruz M, Perez-Cano I, Pellicer A, Gadea B, Martinez M, Fortuno S, Gundersen J, Garrido N, Cruz M, Garrido N, Perez-Cano I, Munoz M, Pellicer A, Martinez M, Gadea B, Selles E, Betersen J, Meseguer M, Le Meaux E, Assou S, Haouzi D, Loup V, Dechaud H, De Vos J, Hamamah S, Ouandaogo G, Assou S, Haouzi D, Ferrieres A, Anahory T, De Vos J, Hamamah S, Monzo C, Assou S, Haouzi D, Pellestor F, Dechaud H, De Vos J, S. Hamamah, Gismano E, Borini A, Cino I, Calzi F, Rabellotti E, Papaleo E, Bianchi V, De Santis L, Sunkara SK, Siozos A, Bolton V, Khalaf Y, Braude P, El-Toukhy T, Cho YS, Ambruosi B, Totaro P, Dell'Aquila ME, Gioacchini G, Bizzaro D, Giorgini E, Ferraris P, Sabbatini S, Carnevali O, Knaggs P, Chau A, Khalil S, Trew G, Lavery S, Jovanovic VP, Gomez R, Sauer CM, Shawber CJ, Outtz HH, Wang X, Sauer MV, Kitajewski J, Zimmermann RC, Mahrous E, Clarke H, Virant-Klun I, Bacer-Kermavner L, Mivsek J, Tomazevic T, Pozlep B, Zorn B, Vrtacnik-Bokal E, Dundure I, Bazarova J, Fodina V, Brikune J, Lakutins J, Jee B, Jo J, Lee J, Suh C, Kim S, Moon S, Shufaro Y, Lebovich M, Aizenman E, Simon A, Laufer N, A. Saada Reisch, Ribeiro MA, Pinto A, Gomes F, Silva Carvalho JL, Almeida H, Massaro FC, Petersen CG, Mauri AL, Silva LFI, Nicoletti APM, Cavagna M, Pontes A, Baruffi RLR, Oliveira JBA, Franco JG, Valcarcel A, Viglierchio MI, Tiveron M, Guidobono M, Inza R, Vilela M, Vilela M, Valcarcel A, Viglierchio MI, Kenny A, Lombardi C, Marconi G. Posters * Embryology (Embryo Selection). Hum Reprod 2010. [DOI: 10.1093/humrep/de.25.s1.140] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
35
|
Vultaggio A, Matucci A, Nencini F, Pratesi S, Parronchi P, Rossi O, Romagnani S, Maggi E. Anti-infliximab IgE and non-IgE antibodies and induction of infusion-related severe anaphylactic reactions. Allergy 2010; 65:657-61. [PMID: 19951375 DOI: 10.1111/j.1398-9995.2009.02280.x] [Citation(s) in RCA: 170] [Impact Index Per Article: 12.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
Abstract
BACKGROUND Infliximab is a chimeric monoclonal antibody against TNF-alpha useful in the treatment of many chronic inflammatory diseases. Severe anaphylaxis has been reported during therapy, although the exact mechanism has not been fully defined. The reactions have been related to the infliximab immunogenicity and development of specific antibodies. AIMS OF THE STUDY Evaluation of the development of IgE and non-IgE antibodies to infliximab and their relationship with infusion reaction. METHODS Seventy-one patients (11 reactives, 11 therapeutically nonresponders, and 49 unreactive therapeutically responders) and 20 non-infliximab-exposed control subjects (ten rheumatoid arthritis, five spondyloarthropathies, five vasculitis) were evaluated for the presence of IgE (ImmunoCAP assay), IgM, and non-isotype-specific (ELISA assays) anti-infliximab antibodies. Sera were obtained at baseline and during the course of treatment, before each infliximab infusion. RESULTS Eleven out of 71 patients had a hypersensitivity reaction to infliximab. Non-isotype-specific anti-infliximab antibodies were detected in eight reactive and two nonresponder patients. Three patients with severe reactions displayed anti-infliximab IgE antibodies and positive skin testing. Detectable levels of anti-infliximab IgM antibodies were shown in three additional IgE- and skin testing-negative patients. IgE and IgM antibodies to infliximab were not detectable in the two nonresponder patients. Antibodies developed before the 2nd and the 3rd infusion, and their appearance was strictly related to the timing of the reaction. CONCLUSIONS This report indicates that in some patients with infliximab-related severe reactions, IgE or IgM antibodies against infliximab were detectable. The majority of reactions could be predicted by the appearance of anti-infliximab antibodies.
Collapse
Affiliation(s)
- A Vultaggio
- Department of Biomedicine, Policlinico di Careggi, Florence, Italy
| | | | | | | | | | | | | | | |
Collapse
|
36
|
Zagli G, Bonizzoli M, Spina R, Cianchi G, Pasquini A, Anichini V, Matano S, Tarantini F, Di Filippo A, Maggi E, Peris A. Effects of hemoperfusion with an immobilized polymyxin-B fiber column on cytokine plasma levels in patients with abdominal sepsis. Minerva Anestesiol 2010; 34:360. [PMID: 20473253 DOI: 10.1016/j.medin.2009.07.007] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/14/2009] [Revised: 07/03/2009] [Accepted: 07/11/2009] [Indexed: 02/06/2023]
Abstract
AIM The beneficial role of hemofiltration with immobilized polymyxin-B fiber (PMX) columns in sepsis, especially sepsis due to gram-negative bacteria, has previously been emphasized. Although the efficacy of PMX-B fiber-mediated hemofiltration in reducing plasma levels of cytokines has been reported, other studies did not confirm this observation. Here we report the effects of PMX-B fiber-mediated hemofiltration on outcome and cytokine plasma levels in patients with abdominal sepsis. METHODS Twelve consecutive patients admitted to the Intensive Care Unit (October 2006-December 2007) for severe sepsis/septic shock from abdominal infection were treated with standard therapy and 2 cycles of hemofiltration with PMX cartridges. Clinical data and plasma levels of IL-6, IL-10 and TNF-a were measured 24 hours before and after PMX treatment. RESULTS Plasma concentrations (pg/mL) of IL-6, IL-10 and TNF-a were significantly lower after hemofiltration with a PMX fiber column (279.9+/-69.2 vs. 130.9+/-18.4, 166.4+/-36.7 vs. 45.5+/-12.2, 83.1+/-13.5 vs. 23.9+/-5.1 pg/mL, respectively; P<0.05). After treatment, patients required lower doses of norepinephrine (0.3+/-0.1 vs. 0.8+/-0.1 mg/kg/min) and reduced lactate levels, recovery of respiratory function and improved Simplified Organ Failure Assessment (SOFA) scores. After 28 days, 6 patients (50%) had survived. Subgroup analysis demonstrated that survivors had higher IL-6 and lower IL-10 and TNF-a pre-treatment plasma levels (pg/mL) compared with deceased patients (324.4+/-41.1 vs.235.3+/-38.4; 98.5+/-16.1 vs. 234.3+/-48.6, 44.5+/-9.0 vs.121.6+/-52.3 pg/mL, respectively; P<0.05). No adverse events imputable to the treatment were recorded. CONCLUSION Hemofiltration with a PMX fiber column was able to reduce plasma levels of IL-6, IL-10 and TNF-a, especially in patients surviving at 28 days. Use of the technique was associated with lower norepinephrine support and an increased PaO2/FiO2 ratio.
Collapse
Affiliation(s)
- G Zagli
- Intensive Care Unit of Emergency Department, Careggi Teaching Hospital and University of Florence, Florence, Italy.
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
37
|
Abstract
Allergen-specific immunotherapy is recognized as a highly effective practice in the treatment of patients with severe allergic rhinitis and/or asthma and is recommended by World Health Organization as an integrated part of allergy management strategy. Several studies have shown that allergen-specific immunotherapy, based on the administration of increasing doses of allergen, achieves a hyposensitization and reduces both early and late responses occurring during the natural exposure to the allergen itself. This is the unique antigen-specific immunomodulatory treatment in current use for human diseases. Successful immunotherapy is associated with reductions in symptoms and medication scores and improved quality of life. After interruption it usually confers long-term remission of symptoms and prevents the onset of new sensitizations in children up to a number of years. Subcutaneous immunotherapy usually suppresses the allergen-induced late response in target organs, likely due to the reduction of the infiltration of T cells, eosinophils, basophils, mast cells and neutrophils. In addition to the reduction of cells of allergic inflammation, immunotherapy also decreases inflammatory mediators at the site of allergen exposure. This review provides an update on the immunological T cell responses induced by conventional subcutaneous and sublingual immunotherapy, and gives a unifying view to reconciling the old dualism between immunoredirecting and immunoregulating mechanisms.
Collapse
Affiliation(s)
- E Maggi
- Department of Internal Medicine, Center of Research, Transfer and High Education DENOTHE, University of Florence, Florence, Italy.
| |
Collapse
|
38
|
Martin S, Esser P, Schmucker S, Pennino D, Geiger R, Maggi E, Dietz L, Thierse H, Richter A, Cavani A, Sallusto F. Development Of In Vitro T Cell Priming Assays For Identification Of Contact Allergens And Respiratory Sensitizers. J Allergy Clin Immunol 2010. [DOI: 10.1016/j.jaci.2009.12.358] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
|
39
|
Bonini S, Bonifazi F, Maggi E, Mascialino B, Melioli G, Mussap M, Passalacqua G, Rossi R, Vacca A, Canonica G. Allergen Component Resolved Diagnostics in Multi-Sensitized Patients with Respiratory Symptoms. J Allergy Clin Immunol 2010. [DOI: 10.1016/j.jaci.2009.12.536] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
40
|
Filì L, Cardilicchia E, Casini A, Maggi L, Manuelli C, Fassio F, Matucci A, Vultaggio A, Annunziato F, Occhiato E, Maggi E, Romagnani S, Parronchi P. A Modified Adenine Chemically Coupled to Allergenic Molecule(s) as Inducer of Allergen-specific Th2 Cells Redirection. J Allergy Clin Immunol 2010. [DOI: 10.1016/j.jaci.2009.12.516] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
|
41
|
Pachi A, Maggi E, Ferrero A, Giancotti A, Marceca M, Matone M, Castelli R. Umbilical artery blood flow in pregnancies complicated by insulin-dependent diabetes mellitus. J OBSTET GYNAECOL 2009. [DOI: 10.3109/01443619309151730] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]
|
42
|
Pachi A, Maggi E, Giancotti A, Torcia F, Frontali M. Antenatal diagnosis of fetal skeletal malformations in ‘at risk' cases. J OBSTET GYNAECOL 2009. [DOI: 10.3109/01443619109013494] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]
|
43
|
Maggi E, Parronchi P, Macchia D, Borrello MG, Biswas P, Biassoni D, Simonelli C, Bellesi G, Gallo O, Pierotti, Romagnani S. CD4 + T Cells from Lymph Nodes Involved by Hodgkin's Disease Showing Response in Autologous Mixed Lymphocyte Reaction, are Polyclonal. Leuk Lymphoma 2009; 2:215-22. [DOI: 10.3109/10428199009053526] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]
|
44
|
Vultaggio A, Matucci A, Virgili G, Rossi O, Filì L, Parronchi P, Romagnani S, Maggi E. Influence of total serum IgE levels on thein vitrodetection of β-lactams-specific IgE antibodies. Clin Exp Allergy 2009; 39:838-44. [DOI: 10.1111/j.1365-2222.2009.03219.x] [Citation(s) in RCA: 32] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
45
|
García-Charton J, Pérez-Ruzafa A, Marcos C, Claudet J, Badalamenti F, Benedetti-Cecchi L, Falcón J, Milazzo M, Schembri P, Stobart B, Vandeperre F, Brito A, Chemello R, Dimech M, Domenici P, Guala I, Le Diréach L, Maggi E, Planes S. Effectiveness of European Atlanto-Mediterranean MPAs: Do they accomplish the expected effects on populations, communities and ecosystems? J Nat Conserv 2008. [DOI: 10.1016/j.jnc.2008.09.007] [Citation(s) in RCA: 121] [Impact Index Per Article: 7.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
|
46
|
Vultaggio A, Matucci A, Parronchi P, Rossi O, Palandri F, Romagnani S, Maggi E. Safety and tolerability of infliximab therapy: suggestions and criticisms based on wide clinical experience. Int J Immunopathol Pharmacol 2008; 21:367-74. [PMID: 18547481 DOI: 10.1177/039463200802100214] [Citation(s) in RCA: 24] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/22/2023] Open
Abstract
Infliximab, an IgG1 monoclonal chimeric antibody against tumor necrosis factor (TNF)-alpha, represents the main biological drug employed for the treatment of several immuno-mediated inflammatory disorders. Infliximab infusion can be complicated by clinically heterogeneous adverse reactions, potentially interfering with the course of treatment. We analysed the adverse events recorded in 49 patients affected by different chronic inflammatory disorders (rheumatoid arthritis, seronegative spondyloarthritis, Behçet's disease, Wegener's granulomatosis, Churg-Strauss syndrome, Cogan's disease) who were receiving a total of 709 infliximab infusions, in order to correlate the development of infliximab reactions and their features to some potential risk factors. We displayed a lower frequency of infusion reactions (1.5 percent; 11 out of 709 infusions) than those previously reported. However, patients suffering from rheumatoid arthritis and/or patients who underwent re-treatment after a long period, showed a higher prevalence of infliximab-related reactions. In conclusion, in our experience infliximab treatment is rarely complicated by adverse reactions which are, more importantly, almost always mild. Some good clinical practices, such as the low rate of infusion, pre-treatment with anti-histamine and prednisone in all patients, chronic immunosuppressive therapy and avoidance of long intervals between infusions may represent a combined useful strategy to reduce the frequency of infliximab reactions and to increase safety.
Collapse
Affiliation(s)
- A Vultaggio
- Department of Biomedicine, Immunoallergology Unit, Policlinico di Careggi, Viale Morgagni 85, Florence, Italy
| | | | | | | | | | | | | |
Collapse
|
47
|
Ledee N, Lombroso R, Lombardelli L, Selva J, Dubanchet S, Chaouat G, Frankenne F, Foidart J, Maggi E, Romagnani S, Ville Y, Piccinni MP. Cytokines and chemokines in follicular fluids and potential of the corresponding embryo: the role of granulocyte colony-stimulating factor. Hum Reprod 2008; 23:2001-9. [DOI: 10.1093/humrep/den192] [Citation(s) in RCA: 103] [Impact Index Per Article: 6.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
48
|
Matà S, Corzani S, Biagiotti R, Piacentini S, Siracusa G, Giudizi MG, Mastio MD, Borsini W, Taiuti R, Vultaggio A, Sorbi S, Maggi E. Influence of impaired T- and B-cell compartments on efficacy of IVIg in dysimmune neuropathies. Eur J Neurol 2007; 14:1147-53. [PMID: 17880569 DOI: 10.1111/j.1468-1331.2007.01929.x] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/16/2022]
Abstract
Autoimmune mechanisms are postulated to play a role in the development and progression of dysimmune neuropathies (DN). We investigated the relation between lymphocyte number and marker expression, and disease activity in 20 patients with DN under intravenous immunoglobulins (IVIg) treatment. B- and T-lymphocyte markers were studied by flow cytometry of the expression of CD5, CD25, CD23 and CD38 markers on B cells and of CD3, CD4 and CD8 markers, respectively. These parameters were compared with those obtained from matched healthy volunteers. The proportions of CD38+ B cells were higher in patients compared with those of controls. Proportions of activated CD4+ and CD8+ T cells were comparable in peripheral blood mononuclear cells of patients and controls, but a significant reduction of the absolute numbers of CD3+, CD4+ and CD8+ cells were observed in DN patients. The percentages of CD25+ memory T cells were instead significantly increased in DN patients. Lastly, T-cell reduction and the CD19/CD38 ratio over total B (CD19+) cells directly correlated with a poor response to IVIg therapy. In DN, whereas T-cell number is reduced, activated T and B cells are increased, thus suggesting an intrinsic defect of the immune response.
Collapse
Affiliation(s)
- S Matà
- Department of Neurological and Psychiatric Sciences, Section of Immunoallergology and Respiratory Disease, University of Firenze, Firenze, Italy.
| | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
49
|
Cosmi L, Santarlasci V, Angeli R, Liotta F, Maggi L, Frosali F, Rossi O, Falagiani P, Riva G, Romagnani S, Annunziato F, Maggi E. Sublingual immunotherapy with Dermatophagoides monomeric allergoid down-regulates allergen-specific immunoglobulin E and increases both interferon-gamma- and interleukin-10-production. Clin Exp Allergy 2006; 36:261-72. [PMID: 16499636 DOI: 10.1111/j.1365-2222.2006.02429.x] [Citation(s) in RCA: 131] [Impact Index Per Article: 7.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/13/2023]
Abstract
BACKGROUND The clinical efficacy and safety of sublingual immunotherapy (SLIT) for aeroallergens has been demonstrated in several trials, whereas the immunological changes induced by this treatment, which may account for the clinical improvement, are still unclear. OBJECTIVE To investigate the effects of a successful SLIT on the in vitro allergen-driven T cell response and cytokine secretion as well as on the serum levels of chemokines and of IgE, IgG1 and IgG4 antibodies (Abs). MATERIALS AND METHODS Twenty-five Dermatophagoides pteronyssinus (Dp)-sensitive patients with perennial rhinitic and/or rhinitic and asthmatic symptoms were randomized into two groups (13 untreated (UT) and 12 SLIT-treated) for a 1 year and half study. The proliferative response of peripheral blood mononuclear cell (PBMC) to purified Der p1 allergen, their cytokines (IFN-gamma, IL-4, IL-10 and TGF-beta) production and serum levels of chemokines associated with T helper type 1 (Th1) (CXCL10) or T helper type 2 (Th2) (CCL22) responses and of Dp-specific IgE, IgG1 and IgG4 Abs were evaluated before and after 6 months of treatment. RESULTS SLIT induced a significant reduction of symptom medication scores after 6, 12 and 18 months of treatment in comparison with UT patients. SLIT-treated patients showed a significant decrease in serum levels of DP-specific IgE Abs, whereas total IgE, and specific IgG1 and IgG4 Abs remained unchanged. The proliferative response of allergen-specific T cells to Der p1 in vitro after 6 months of treatment was reduced, while no effect was observed on T cell proliferation to recall antigen (streptokinase). Moreover, Der p1-driven IFN-gamma and IL-10 were significantly increased in culture supernatants of PBMC from 6 month-treated patients in comparison with those detected at the beginning of therapy. CONCLUSIONS These data suggest that the allergen-driven enhancement of IL-10- and IFN-gamma-producing T cells precedes and associates with SLIT-induced down-regulation of specific IgE, thus providing a rationale to explain the clinical benefit of SLIT in allergic patients.
Collapse
Affiliation(s)
- L Cosmi
- Center of Research, Transfer, High Education 'DENOthe', University of Florence, Firenze, Italy
| | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
50
|
Annunziato F, Cosmi L, Liotta F, Lazzeri E, Romagnani P, Angeli R, Lasagni L, Manetti R, Marra F, Gerard C, Petrai I, Dello Sbarba P, Tonelli F, Maggi E, Romagnani S. CXCR3 and alphaEbeta7 integrin identify a subset of CD8+ mature thymocytes that share phenotypic and functional properties with CD8+ gut intraepithelial lymphocytes. Gut 2006; 55:961-8. [PMID: 16368781 PMCID: PMC1856348 DOI: 10.1136/gut.2005.077560] [Citation(s) in RCA: 25] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/30/2023]
Abstract
BACKGROUND We previously demonstrated the existence of two distinct subsets of T cell receptor (TCR)alphabeta+CD8alphabeta+ single positive (SP) cells in human postnatal thymus which express the chemokine receptor CCR7 or CXCR3 and migrate in vitro in response to their specific ligands. AIM To investigate whether these two CD8+ thymocyte subsets had distinct peripheral colonisation. METHODS TCRalphabeta+CD8+ SP cells were obtained from normal postnatal thymus, mesenteric lymph node (LNs), small bowel, and peripheral blood (PB) specimens. Cells were then evaluated for expression of surface molecules, cytolytic potential, telomere length, and profile of cytokine production. RESULTS CD8+CCR7+CXCR3- thymocytes exhibited CD62L, in common with those which localise to LNs. In contrast, CD8+CCR7-CXCR3+ thymocytes lacked CD62L but exhibited CD103, similar to intraepithelial lymphocytes (IELs) present in the gut mucosa where the CXCR3 ligand, CXCL10, and the CD103 ligand, E-cadherin, are highly and consistently expressed. In addition, thymocytes and gut CD8+CXCR3+CD103+ cells showed comparable telomere length, which was higher than that of PB CXCR3+CD8+ T cells. However, both of these populations contained perforin and granzyme A, and displayed the ability to produce interferon gamma and interleukin 2. Of note, CXCR3 deficient, in comparison with wild-type C57Black/6, mice showed decreased proportions of CD3+CD8alphabeta+ and increased proportions of CD3+CD8alphaalpha+ lymphocytes at gut level. Moreover, adoptive transfer of CD3+CD8alphabeta+ thymocytes from wild-type into CXCR3 deficient mice resulted in a significant increase in CD3+CD8alphabeta+ T cells in the gut mucosa but not in other tissues. CONCLUSIONS The results of this study demonstrate the existence of a previously unrecognised subset of TCRalphabeta+CD8alphabeta+ SP CXCR3+CD103+ thymocytes which share phenotypic and functional features with CD8+ IELs, thus suggesting the possibility of their direct colonisation of the gut mucosa.
Collapse
MESH Headings
- Adoptive Transfer
- Adult
- Analysis of Variance
- Animals
- CD8-Positive T-Lymphocytes/chemistry
- CD8-Positive T-Lymphocytes/immunology
- CD8-Positive T-Lymphocytes/ultrastructure
- Cell Separation/methods
- Child, Preschool
- Flow Cytometry
- Humans
- Immunohistochemistry/methods
- Infant
- Infant, Newborn
- Integrins/analysis
- Interleukins/biosynthesis
- Intestinal Mucosa/immunology
- Male
- Mice
- Mice, Knockout
- Mice, Mutant Strains
- Receptors, Antigen, T-Cell, alpha-beta/analysis
- Receptors, CCR7
- Receptors, CXCR3
- Receptors, Chemokine/analysis
- Receptors, Chemokine/genetics
- Telomere/ultrastructure
Collapse
Affiliation(s)
- F Annunziato
- Center for Research, Transfer, and High Education DENOthe, Dipartimento di Medicina Interna, Università di Firenze, Viale Morgagni 85, Firenze 50134 Italy
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|